reference_id,authors,title,journal,year,volume,citation_footer,citation_type,citation,urls,pubmed_id,doi,header,reference_type,study_id,exclusion_reason
CD008170-bib-0001,ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial. ,Major outcomes in high‐risk hypertensive patients randomized to angiotensin‐converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), JAMA ,2002,288,    ,['citation-journal'], ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high‐risk hypertensive patients randomized to angiotensin‐converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).  JAMA 2002;288(23):2981‐97. CENTRAL    Link to article     PubMed     ,"['', 'https://doi.org/10.1001/jama.288.23.2981', 'https://www.ncbi.nlm.nih.gov/pubmed/12479763']",12479763,https://doi.org/10.1001/jama.288.23.2981, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0002,"Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, et al. ",Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), Archives of Internal Medicine ,2006,166,    ,['citation-journal']," Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, et al. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).  Archives of Internal Medicine 2006;166(20):2191‐2201. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/17101936', 'https://scholar.google.com/scholar_lookup?title=Fasting+glucose+levels+and+incident+diabetes+mellitus+in+older+nondiabetic+adults+randomized+to+receive+3+different+classes+of+antihypertensive+treatment:+a+report+from+the+Antihypertensive+and+Lipid‐Lowering+Treatment+to+Prevent+Heart+Attack+Trial+(ALLHAT)+&author=JI+Barzilay&author=BR+Davis&author=JA+Cutler&author=SL+Pressel&author=PK+Whelton&author=J+Basile&publication_year=2006&hl=en']",17101936,, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0003,"Barzilay JI, Jones CL, Davis BR, Basile JN, Goff DC, Ciocon JO, et al. ",Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), Diabetes Care ,2001,24,    ,['citation-journal']," Barzilay JI, Jones CL, Davis BR, Basile JN, Goff DC, Ciocon JO, et al. Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).  Diabetes Care 2001;24(4):654‐8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.2337/diacare.24.4.654', 'https://www.ncbi.nlm.nih.gov/pubmed/11315826', 'https://scholar.google.com/scholar_lookup?title=Baseline+characteristics+of+the+diabetic+participants+in+the+Antihypertensive+and+Lipid‐Lowering+Treatment+to+Prevent+Heart+Attack+Trial+(ALLHAT)+&author=JI+Barzilay&author=CL+Jones&author=BR+Davis&author=JN+Basile&author=DC+Goff&author=JO+Ciocon&publication_year=2001&hl=en']",11315826,https://doi.org/10.2337/diacare.24.4.654, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0004,"Black HR, Davis B, Barzilay J, Nwachuku C, Baimbridge C, Marginean H, et al. ","Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)", Diabetes Care ,2008,31,    ,['citation-journal']," Black HR, Davis B, Barzilay J, Nwachuku C, Baimbridge C, Marginean H, et al. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).  Diabetes Care 2008;31(2):353‐60. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/18000186', 'https://scholar.google.com/scholar_lookup?title=Metabolic+and+clinical+outcomes+in+nondiabetic+individuals+with+the+metabolic+syndrome+assigned+to+chlorthalidone,+amlodipine,+or+lisinopril+as+initial+treatment+for+hypertension:+a+report+from+the+Antihypertensive+and+Lipid‐Lowering+Treatment+to+Prevent+Heart+Attack+Trial+(ALLHAT)+&author=HR+Black&author=B+Davis&author=J+Barzilay&author=C+Nwachuku&author=C+Baimbridge&author=H+Marginean&publication_year=2008&hl=en']",18000186,, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0005,"Cushman WC, Ford CE, Einhorn P, Wright JT, Preston RA, Davis BR, Basile JN. ",Blood pressure control by randomized drug group in ALLHAT, American Journal of Hypertension ,2004,17,    ,['citation-journal']," Cushman WC, Ford CE, Einhorn P, Wright JT, Preston RA, Davis BR, Basile JN. Blood pressure control by randomized drug group in ALLHAT.  American Journal of Hypertension 2004;17(5):30A. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.amjhyper.2004.03.069', 'https://scholar.google.com/scholar_lookup?title=Blood+pressure+control+by+randomized+drug+group+in+ALLHAT&author=WC+Cushman&author=CE+Ford&author=P+Einhorn&author=JT+Wright&author=RA+Preston&author=BR+Davis&author=JN+Basile&publication_year=2004&hl=en']",,https://doi.org/10.1016/j.amjhyper.2004.03.069, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0006,"Davis BR, Kostis JB, Simpson LM, Black HR, Cushman WC, Einhorn PT, et al. ",Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid‐lowering treatment to prevent heart attack trial, Circulation ,2008,118,    ,['citation-journal']," Davis BR, Kostis JB, Simpson LM, Black HR, Cushman WC, Einhorn PT, et al. Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid‐lowering treatment to prevent heart attack trial.  Circulation 2008;118(22):2259‐67. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1161/CIRCULATIONAHA.107.762229', 'https://www.ncbi.nlm.nih.gov/pubmed/19001024', 'https://scholar.google.com/scholar_lookup?title=Heart+failure+with+preserved+and+reduced+left+ventricular+ejection+fraction+in+the+antihypertensive+and+lipid‐lowering+treatment+to+prevent+heart+attack+trial+&author=BR+Davis&author=JB+Kostis&author=LM+Simpson&author=HR+Black&author=WC+Cushman&author=PT+Einhorn&publication_year=2008&hl=en']",19001024,https://doi.org/10.1161/CIRCULATIONAHA.107.762229, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0007,"Davis BR, Piller LB, Cutler JA, Furberg C, Dunn K, Franklin S, et al. ",Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial, Circulation ,2006,113,    ,['citation-journal']," Davis BR, Piller LB, Cutler JA, Furberg C, Dunn K, Franklin S, et al. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial.  Circulation 2006;113(18):2201‐10. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1161/CIRCULATIONAHA.105.544031', 'https://www.ncbi.nlm.nih.gov/pubmed/16651474', 'https://scholar.google.com/scholar_lookup?title=Role+of+diuretics+in+the+prevention+of+heart+failure:+the+Antihypertensive+and+Lipid‐Lowering+Treatment+to+Prevent+Heart+Attack+Trial+&author=BR+Davis&author=LB+Piller&author=JA+Cutler&author=C+Furberg&author=K+Dunn&author=S+Franklin&publication_year=2006&hl=en']",16651474,https://doi.org/10.1161/CIRCULATIONAHA.105.544031, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0008,"Grimm RH, Davis BR, Cutler JA, Piller LB, Margolis K, Barzilay J, et al. ",Did blood pressure medication withdrawal prior to randomization influence subsequent rates of heart failure in the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial?, Journal of the American College of Cardiology ,2007,49,    ,['citation-journal']," Grimm RH, Davis BR, Cutler JA, Piller LB, Margolis K, Barzilay J, et al. Did blood pressure medication withdrawal prior to randomization influence subsequent rates of heart failure in the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial?.  Journal of the American College of Cardiology 2007;49(9 Suppl A):350a. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Did+blood+pressure+medication+withdrawal+prior+to+randomization+influence+subsequent+rates+of+heart+failure+in+the+Antihypertensive+and+Lipid‐Lowering+Treatment+to+Prevent+Heart+Attack+Trial?+&author=RH+Grimm&author=BR+Davis&author=JA+Cutler&author=LB+Piller&author=K+Margolis&author=J+Barzilay&publication_year=2007&hl=en']",,, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0009,"Grimm RH, Davis BR, Piller LB, Cutler JA, Margolis KL, Barzilay J, et al. ",Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome?, Journal of Clinical Hypertension ,2009,11,    ,['citation-journal']," Grimm RH, Davis BR, Piller LB, Cutler JA, Margolis KL, Barzilay J, et al. Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome?.  Journal of Clinical Hypertension 2009;11(9):466‐74. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/j.1751-7176.2009.00149.x', 'https://www.ncbi.nlm.nih.gov/pubmed/19751458', 'https://scholar.google.com/scholar_lookup?title=Heart+failure+in+ALLHAT:+did+blood+pressure+medication+at+study+entry+influence+outcome?&author=RH+Grimm&author=BR+Davis&author=LB+Piller&author=JA+Cutler&author=KL+Margolis&author=J+Barzilay&publication_year=2009&hl=en']",19751458,https://doi.org/10.1111/j.1751-7176.2009.00149.x, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0010,"Haywood LJ, Ford CE, Crow RS, Davis BR, Massie BM, Einhorn PT, et al. ",Atrial fibrillation at baseline and during follow‐up in ALLHAT (Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial), Journal of the American College of Cardiology ,2009,54,    ,['citation-journal']," Haywood LJ, Ford CE, Crow RS, Davis BR, Massie BM, Einhorn PT, et al. Atrial fibrillation at baseline and during follow‐up in ALLHAT (Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial).  Journal of the American College of Cardiology 2009;54(22):2023‐31. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/j.jacc.2009.08.020', 'https://www.ncbi.nlm.nih.gov/pubmed/19926008', 'https://scholar.google.com/scholar_lookup?title=Atrial+fibrillation+at+baseline+and+during+follow‐up+in+ALLHAT+(Antihypertensive+and+Lipid‐Lowering+Treatment+to+Prevent+Heart+Attack+Trial)+&author=LJ+Haywood&author=CE+Ford&author=RS+Crow&author=BR+Davis&author=BM+Massie&author=PT+Einhorn&publication_year=2009&hl=en']",19926008,https://doi.org/10.1016/j.jacc.2009.08.020, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0011,"Leenen FH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM, et al. ",Clinical events in high‐risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin‐converting enzyme inhibitor in the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial, Hypertension ,2006,48,    ,['citation-journal']," Leenen FH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM, et al. Clinical events in high‐risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin‐converting enzyme inhibitor in the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial.  Hypertension 2006;48(3):374‐84. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1161/01.HYP.0000231662.77359.de', 'https://www.ncbi.nlm.nih.gov/pubmed/16864749', 'https://scholar.google.com/scholar_lookup?title=Clinical+events+in+high‐risk+hypertensive+patients+randomly+assigned+to+calcium+channel+blocker+versus+angiotensin‐converting+enzyme+inhibitor+in+the+Antihypertensive+and+Lipid‐Lowering+Treatment+to+Prevent+Heart+Attack+Trial+&author=FH+Leenen&author=CE+Nwachuku&author=HR+Black&author=WC+Cushman&author=BR+Davis&author=LM+Simpson&publication_year=2006&hl=en']",16864749,https://doi.org/10.1161/01.HYP.0000231662.77359.de, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0012,"Lynch AI, Boerwinkle E, Davis BR, Ford CE, Eckfeldt JH, Leiendecker‐Foster C, et al. ","Antihypertensive pharmacogenetic effect of fibrinogen‐beta variant ‐455G>A on cardiovascular disease, end‐stage renal disease, and mortality: the GenHAT study", Pharmacogenetics and Genomics ,2009,19,    ,['citation-journal']," Lynch AI, Boerwinkle E, Davis BR, Ford CE, Eckfeldt JH, Leiendecker‐Foster C, et al. Antihypertensive pharmacogenetic effect of fibrinogen‐beta variant ‐455G>A on cardiovascular disease, end‐stage renal disease, and mortality: the GenHAT study.  Pharmacogenetics and Genomics 2009;19(6):415‐21. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/FPC.0b013e32832a8e81', 'https://www.ncbi.nlm.nih.gov/pubmed/19352213', 'https://scholar.google.com/scholar_lookup?title=Antihypertensive+pharmacogenetic+effect+of+fibrinogen‐beta+variant+‐455G>A+on+cardiovascular+disease,+end‐stage+renal+disease,+and+mortality:+the+GenHAT+study+&author=AI+Lynch&author=E+Boerwinkle&author=BR+Davis&author=CE+Ford&author=JH+Eckfeldt&author=C+Leiendecker‐Foster&publication_year=2009&hl=en']",19352213,https://doi.org/10.1097/FPC.0b013e32832a8e81, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0013,"Lynch AI, Boerwinkle E, Davis BR, Ford CE, Eckfeldt JH, Leiendecker‐Foster C, et al. ",Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension. [Erratum appears in JAMA. 2009 Sep 9;302(10):1057‐8], JAMA ,2008,299,    ,['citation-journal']," Lynch AI, Boerwinkle E, Davis BR, Ford CE, Eckfeldt JH, Leiendecker‐Foster C, et al. Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension. [Erratum appears in JAMA. 2009 Sep 9;302(10):1057‐8].  JAMA 2008;299(3):296‐307. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/18212314', 'https://scholar.google.com/scholar_lookup?title=Pharmacogenetic+association+of+the+NPPA+T2238C+genetic+variant+with+cardiovascular+disease+outcomes+in+patients+with+hypertension.+[Erratum+appears+in+JAMA.+2009+Sep+9;302(10):1057‐8]+&author=AI+Lynch&author=E+Boerwinkle&author=BR+Davis&author=CE+Ford&author=JH+Eckfeldt&author=C+Leiendecker‐Foster&publication_year=2008&hl=en']",18212314,, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0014,"Probstfield JL, Cushman WC, Davis BR, Pressel S, Cutler JA, Einhorn P, et al. ",Mortality and morbidity during and after the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT),,2010,,    ,['citation-other']," Probstfield JL, Cushman WC, Davis BR, Pressel S, Cutler JA, Einhorn P, et al. Mortality and morbidity during and after the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). European Society of Cardiology, ESC Congress; 2010 Aug 28‐Sep 1; Stockholm, Sweden. 2010; Vol. 31:321. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Mortality+and+morbidity+during+and+after+the+Antihypertensive+and+Lipid‐Lowering+Treatment+to+Prevent+Heart+Attack+Trial+(ALLHAT)+&author=JL+Probstfield&author=WC+Cushman&author=BR+Davis&author=S+Pressel&author=JA+Cutler&author=P+Einhorn&publication_year=2010&hl=en']",,, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0015,"Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, et al. ",Renal outcomes in high‐risk hypertensive patients treated with an angiotensin‐converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), Archives of Internal Medicine ,2005,165,    ,['citation-journal']," Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, et al. Renal outcomes in high‐risk hypertensive patients treated with an angiotensin‐converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).  Archives of Internal Medicine 2005;165(8):936‐46. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/15851647', 'https://scholar.google.com/scholar_lookup?title=Renal+outcomes+in+high‐risk+hypertensive+patients+treated+with+an+angiotensin‐converting+enzyme+inhibitor+or+a+calcium+channel+blocker+vs+a+diuretic:+a+report+from+the+Antihypertensive+and+Lipid‐Lowering+Treatment+to+Prevent+Heart+Attack+Trial+(ALLHAT)+&author=M+Rahman&author=S+Pressel&author=BR+Davis&author=C+Nwachuku&author=JT+Wright&author=PK+Whelton&publication_year=2005&hl=en']",15851647,, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0016,"Wright JT, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, et al. ","Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril", JAMA ,2005,293,    ,['citation-journal']," Wright JT, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.  JAMA 2005;293(13):1595‐608. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1001/jama.293.13.1595', 'https://www.ncbi.nlm.nih.gov/pubmed/15811979', 'https://scholar.google.com/scholar_lookup?title=Outcomes+in+hypertensive+black+and+nonblack+patients+treated+with+chlorthalidone,+amlodipine,+and+lisinopril+&author=JT+Wright&author=JK+Dunn&author=JA+Cutler&author=BR+Davis&author=WC+Cushman&author=CE+Ford&publication_year=2005&hl=en']",15811979,https://doi.org/10.1001/jama.293.13.1595, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0017,"Wright JT, Harris‐Haywood S, Pressel S, Barzilay J, Baimbridge C, Bareis CJ, et al. ",Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), Archives of Internal Medicine ,2008,168,    ,['citation-journal']," Wright JT, Harris‐Haywood S, Pressel S, Barzilay J, Baimbridge C, Bareis CJ, et al. Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).  Archives of Internal Medicine 2008;168(2):207‐17. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1001/archinternmed.2007.66', 'https://www.ncbi.nlm.nih.gov/pubmed/18227370', 'https://scholar.google.com/scholar_lookup?title=Clinical+outcomes+by+race+in+hypertensive+patients+with+and+without+the+metabolic+syndrome:+Antihypertensive+and+Lipid‐Lowering+Treatment+to+Prevent+Heart+Attack+Trial+(ALLHAT)+&author=JT+Wright&author=S+Harris‐Haywood&author=S+Pressel&author=J+Barzilay&author=C+Baimbridge&author=CJ+Bareis&publication_year=2008&hl=en']",18227370,https://doi.org/10.1001/archinternmed.2007.66, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0018,"Zhang X, Lynch AI, Davis BR, Ford CE, Boerwinkle E, Eckfeldt JH, et al. ",Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study, PLoS ONE [Electronic Resource] ,2012,7,    ,['citation-journal']," Zhang X, Lynch AI, Davis BR, Ford CE, Boerwinkle E, Eckfeldt JH, et al. Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study.  PLoS ONE [Electronic Resource] 2012;7(3):e34217. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1371/journal.pone.0034217', 'https://scholar.google.com/scholar_lookup?title=Pharmacogenetic+association+of+NOS3+variants+with+cardiovascular+disease+in+patients+with+hypertension:+the+GenHAT+study+&author=X+Zhang&author=AI+Lynch&author=BR+Davis&author=CE+Ford&author=E+Boerwinkle&author=JH+Eckfeldt&publication_year=2012&hl=en']",,https://doi.org/10.1371/journal.pone.0034217, ALLHAT 2002 {published data only}  ,included,CD008170-bbs2-0001,
CD008170-bib-0019,"Ariff B, Zambanini A, Vamadeva S, Barratt D, Xu Y, Sever P, et al. ",Candesartan‐ and atenolol‐based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension, Stroke ,2006,37,    ,['citation-journal']," Ariff B, Zambanini A, Vamadeva S, Barratt D, Xu Y, Sever P, et al. Candesartan‐ and atenolol‐based treatments induce different patterns of carotid artery and left ventricular remodeling in hypertension.  Stroke 2006;37(9):2381‐4. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1161/01.STR.0000236839.69658.c5', 'https://www.ncbi.nlm.nih.gov/pubmed/16888272', 'https://scholar.google.com/scholar_lookup?title=Candesartan‐+and+atenolol‐based+treatments+induce+different+patterns+of+carotid+artery+and+left+ventricular+remodeling+in+hypertension+&author=B+Ariff&author=A+Zambanini&author=S+Vamadeva&author=D+Barratt&author=Y+Xu&author=P+Sever&publication_year=2006&hl=en']",16888272,https://doi.org/10.1161/01.STR.0000236839.69658.c5, Ariff 2006 {published data only}  ,included,CD008170-bbs2-0002,
CD008170-bib-0020,"Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, Brusegan V, et al. ",Preventing microalbuminuria in type 2 diabetes, New England Journal of Medicine ,2004,351,    ,['citation-journal']," Ruggenenti P, Fassi A, Ilieva AP, Bruno S, Iliev IP, Brusegan V, et al. Preventing microalbuminuria in type 2 diabetes.  New England Journal of Medicine 2004;351(19):1941‐51. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1056/NEJMoa042167', 'https://scholar.google.com/scholar_lookup?title=Preventing+microalbuminuria+in+type+2+diabetes&author=P+Ruggenenti&author=A+Fassi&author=AP+Ilieva&author=S+Bruno&author=IP+Iliev&author=V+Brusegan&publication_year=2004&hl=en']",,https://doi.org/10.1056/NEJMoa042167, BENEDICT 2004 (formerly Ruggenenti 2004) {published data only}  ,included,CD008170-bbs2-0003,
CD008170-bib-0021,"Buus NH, Bottcher M, Jorgensen CG, Christensen KL, Thygesen K, Nielsen TT, et al. ",Myocardial perfusion during long‐term angiotensin‐converting enzyme inhibition or beta‐blockade in patients with essential hypertension, Hypertension ,2004,44,    ,['citation-journal']," Buus NH, Bottcher M, Jorgensen CG, Christensen KL, Thygesen K, Nielsen TT, et al. Myocardial perfusion during long‐term angiotensin‐converting enzyme inhibition or beta‐blockade in patients with essential hypertension.  Hypertension 2004;44(4):465‐70. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1161/01.HYP.0000141273.72768.b7', 'https://www.ncbi.nlm.nih.gov/pubmed/15326083', 'https://scholar.google.com/scholar_lookup?title=Myocardial+perfusion+during+long‐term+angiotensin‐converting+enzyme+inhibition+or+beta‐blockade+in+patients+with+essential+hypertension+&author=NH+Buus&author=M+Bottcher&author=CG+Jorgensen&author=KL+Christensen&author=K+Thygesen&author=TT+Nielsen&publication_year=2004&hl=en']",15326083,https://doi.org/10.1161/01.HYP.0000141273.72768.b7, Buus 2004 {published data only}  ,included,CD008170-bbs2-0004,
CD008170-bib-0022,"Buus NH, Jorgensen CG, Mulvany MJ, Sorensen KE. ",Large and small artery endothelial function in patients with essential hypertension‐‐effect of ACE inhibition and beta‐blockade, Blood Pressure ,2007,16,    ,['citation-journal']," Buus NH, Jorgensen CG, Mulvany MJ, Sorensen KE. Large and small artery endothelial function in patients with essential hypertension‐‐effect of ACE inhibition and beta‐blockade.  Blood Pressure 2007;16(2):106‐13. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1080/08037050701343688', 'https://www.ncbi.nlm.nih.gov/pubmed/17612909', 'https://scholar.google.com/scholar_lookup?title=Large+and+small+artery+endothelial+function+in+patients+with+essential+hypertension‐‐effect+of+ACE+inhibition+and+beta‐blockade+&author=NH+Buus&author=CG+Jorgensen&author=MJ+Mulvany&author=KE+Sorensen&publication_year=2007&hl=en']",17612909,https://doi.org/10.1080/08037050701343688, Buus 2007 {published data only}  ,included,CD008170-bbs2-0005,
CD008170-bib-0023,"Dahlöf B, Hansson L. ",The influence of antihypertensive therapy on the structural arteriolar changes in essential hypertension: different effects of enalapril and hydrochlorothiazide, Journal of Internal Medicine ,1993,234,    ,['citation-journal']," Dahlöf B, Hansson L. The influence of antihypertensive therapy on the structural arteriolar changes in essential hypertension: different effects of enalapril and hydrochlorothiazide.  Journal of Internal Medicine 1993;234(3):271‐9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/j.1365-2796.1993.tb00743.x', 'https://www.ncbi.nlm.nih.gov/pubmed/8354977', 'https://scholar.google.com/scholar_lookup?title=The+influence+of+antihypertensive+therapy+on+the+structural+arteriolar+changes+in+essential+hypertension:+different+effects+of+enalapril+and+hydrochlorothiazide+&author=B+Dahlöf&author=L+Hansson&publication_year=1993&hl=en']",8354977,https://doi.org/10.1111/j.1365-2796.1993.tb00743.x, Dahlöf 1993 {published data only}  ,included,CD008170-bbs2-0006,
CD008170-bib-0024,"Dahlöf B, Zanchetti A, Diez J, Nicholls MG, Yu CM, Barrios V, et al. ",Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy, Journal of Hypertension ,2002,20,    ,['citation-journal']," Dahlöf B, Zanchetti A, Diez J, Nicholls MG, Yu CM, Barrios V, et al. Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy.  Journal of Hypertension 2002;20(9):1855‐64. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/00004872-200209000-00032', 'https://www.ncbi.nlm.nih.gov/pubmed/12195129', 'https://scholar.google.com/scholar_lookup?title=Effects+of+losartan+and+atenolol+on+left+ventricular+mass+and+neurohormonal+profile+in+patients+with+essential+hypertension+and+left+ventricular+hypertrophy+&author=B+Dahlöf&author=A+Zanchetti&author=J+Diez&author=MG+Nicholls&author=CM+Yu&author=V+Barrios&publication_year=2002&hl=en']",12195129,https://doi.org/10.1097/00004872-200209000-00032, Dahlöf 2002 {published data only}  ,included,CD008170-bbs2-0007,
CD008170-bib-0025,"Dalla Vestra M, Pozza G, Mosca A, Grazioli V, Lapolla A, Fioretto P, et al. ","Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina)", Diabetes Nutrition & Metabolism ,2004,17,    ,['citation-journal']," Dalla Vestra M, Pozza G, Mosca A, Grazioli V, Lapolla A, Fioretto P, et al. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).  Diabetes Nutrition & Metabolism 2004;17(5):259‐66. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=Effect+of+lercanidipine+compared+with+ramipril+on+albumin+excretion+rate+in+hypertensive+Type+2+diabetic+patients+with+microalbuminuria:+DIAL+study+(diabete,+ipertensione,+albuminuria,+lercanidipina)+&author=M+DallaVestra&author=G+Pozza&author=A+Mosca&author=V+Grazioli&author=A+Lapolla&author=P+Fioretto&publication_year=2004&hl=en']",,, Dalla 2004 {published data only}  ,included,CD008170-bbs2-0008,
CD008170-bib-0026,"Derosa G, Cicero AF, Bertone G, Piccinni MN, Fogari E, Ciccarelli L, et al. ","Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12‐month, randomized, double‐blind study", Clinical Therapeutics ,2004,26,    ,['citation-journal']," Derosa G, Cicero AF, Bertone G, Piccinni MN, Fogari E, Ciccarelli L, et al. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12‐month, randomized, double‐blind study.  Clinical Therapeutics 2004;26(8):1228‐36. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/15476904', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+the+effects+of+telmisartan+and+nifedipine+gastrointestinal+therapeutic+system+on+blood+pressure+control,+glucose+metabolism,+and+the+lipid+profile+in+patients+with+type+2+diabetes+mellitus+and+mild+hypertension:+a+12‐month,+randomized,+double‐blind+study+&author=G+Derosa&author=AF+Cicero&author=G+Bertone&author=MN+Piccinni&author=E+Fogari&author=L+Ciccarelli&publication_year=2004&hl=en']",15476904,, Derosa 2004 {published data only}  ,included,CD008170-bbs2-0009,
CD008170-bib-0027,"Derosa G, Cicero AF, Gaddi A, Mugellini A, Ciccarelli L, Fogari R. ",Effects of doxazosin and irbesartan on blood pressure and metabolic control in patients with type 2 diabetes and hypertension, Journal of Cardiovascular Pharmacology ,2005,45,    ,['citation-journal']," Derosa G, Cicero AF, Gaddi A, Mugellini A, Ciccarelli L, Fogari R. Effects of doxazosin and irbesartan on blood pressure and metabolic control in patients with type 2 diabetes and hypertension.  Journal of Cardiovascular Pharmacology 2005;45(6):599‐604. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/01.fjc.0000161403.91456.39', 'https://www.ncbi.nlm.nih.gov/pubmed/15897788', 'https://scholar.google.com/scholar_lookup?title=Effects+of+doxazosin+and+irbesartan+on+blood+pressure+and+metabolic+control+in+patients+with+type+2+diabetes+and+hypertension+&author=G+Derosa&author=AF+Cicero&author=A+Gaddi&author=A+Mugellini&author=L+Ciccarelli&author=R+Fogari&publication_year=2005&hl=en']",15897788,https://doi.org/10.1097/01.fjc.0000161403.91456.39, Derosa 2005 {published data only}  ,included,CD008170-bbs2-0010,
CD008170-bib-0028,"Derosa G, Bonaventura A, Bianchi DRL, Fogari E, Angelo AD, Maffioli P. ",Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients, Journal of Clinical Pharmacy and Therapeutics ,2014,39,    ,['citation-journal']," Derosa G, Bonaventura A, Bianchi DRL, Fogari E, Angelo AD, Maffioli P. Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients.  Journal of Clinical Pharmacy and Therapeutics 2014;39:277–85. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/jcpt.12139', 'https://www.ncbi.nlm.nih.gov/pubmed/24635387', 'https://scholar.google.com/scholar_lookup?title=Effects+of+enalapril/lercanidipine+combination+on+some+emerging+biomarkers+in+cardiovascular+risk+stratification+in+hypertensive+patients+&author=G+Derosa&author=A+Bonaventura&author=DRL+Bianchi&author=E+Fogari&author=AD+Angelo&author=P+Maffioli&publication_year=2014&hl=en']",24635387,https://doi.org/10.1111/jcpt.12139, Derosa 2014 {published data only}  ,included,CD008170-bbs2-0011,
CD008170-bib-0029,"Devereux RB, Palmieri V, Sharpe N, De Quattro V, Bella JN, de Simone G, et al. ",Effects of once‐daily angiotensin‐converting enzyme inhibition and calcium channel blockade‐based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial, Circulation ,2001,104,    ,['citation-journal']," Devereux RB, Palmieri V, Sharpe N, De Quattro V, Bella JN, de Simone G, et al. Effects of once‐daily angiotensin‐converting enzyme inhibition and calcium channel blockade‐based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial.  Circulation 2001;104(11):1248‐54. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/11551875', 'https://scholar.google.com/scholar_lookup?title=Effects+of+once‐daily+angiotensin‐converting+enzyme+inhibition+and+calcium+channel+blockade‐based+antihypertensive+treatment+regimens+on+left+ventricular+hypertrophy+and+diastolic+filling+in+hypertension:+the+prospective+randomized+enalapril+study+evaluating+regression+of+ventricular+enlargement+(preserve)+trial+&author=RB+Devereux&author=V+Palmieri&author=N+Sharpe&author=V+Quattro&author=JN+Bella&author=G+Simone&publication_year=2001&hl=en']",11551875,, Devereux 2001 {published data only}  ,included,CD008170-bbs2-0012,
CD008170-bib-0030,"Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, et al. ","The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3‐year, randomized, multicenter, double‐blind, placebo‐controlled study", Clinical Therapeutics ,2008,30,    ,['citation-journal']," Esnault VL, Brown EA, Apetrei E, Bagon J, Calvo C, DeChatel R, et al. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3‐year, randomized, multicenter, double‐blind, placebo‐controlled study.  Clinical Therapeutics 2008;30(3):482‐98. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/j.clinthera.2008.03.006', 'https://www.ncbi.nlm.nih.gov/pubmed/18405787', 'https://scholar.google.com/scholar_lookup?title=The+effects+of+amlodipine+and+enalapril+on+renal+function+in+adults+with+hypertension+and+nondiabetic+nephropathies:+a+3‐year,+randomized,+multicenter,+double‐blind,+placebo‐controlled+study+&author=VL+Esnault&author=EA+Brown&author=E+Apetrei&author=J+Bagon&author=C+Calvo&author=R+DeChatel&publication_year=2008&hl=en']",18405787,https://doi.org/10.1016/j.clinthera.2008.03.006, Esnault 2008 {published data only}  ,included,CD008170-bbs2-0013,
CD008170-bib-0031,"Estacio RO, Jeffers BW, Gifford N, Schrier RW. ",Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes, Diabetes Care ,2000,23,    ,['citation-journal']," Estacio RO, Jeffers BW, Gifford N, Schrier RW. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.  Diabetes Care 2000;23:B54‐64. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/10860192', 'https://scholar.google.com/scholar_lookup?title=Effect+of+blood+pressure+control+on+diabetic+microvascular+complications+in+patients+with+hypertension+and+type+2+diabetes+&author=RO+Estacio&author=BW+Jeffers&author=N+Gifford&author=RW+Schrier&publication_year=2000&hl=en']",10860192,, Estacio 1998 {published data only}  ,included,CD008170-bbs2-0014,
CD008170-bib-0032,"Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW. ",The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension, New England Journal of Medicine ,1998,338,    ,['citation-journal']," Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non‐insulin‐dependent diabetes and hypertension.  New England Journal of Medicine 1998;338(10):645‐52. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1056/NEJM199803053381003', 'https://scholar.google.com/scholar_lookup?title=The+effect+of+nisoldipine+as+compared+with+enalapril+on+cardiovascular+outcomes+in+patients+with+non‐insulin‐dependent+diabetes+and+hypertension+&author=RO+Estacio&author=BW+Jeffers&author=WR+Hiatt&author=SL+Biggerstaff&author=N+Gifford&author=RW+Schrier&publication_year=1998&hl=en']",,https://doi.org/10.1056/NEJM199803053381003, Estacio 1998 {published data only}  ,included,CD008170-bbs2-0014,
CD008170-bib-0033,"Estacio RO, Schrier RW. ",Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial, American Journal of Cardiology ,1998,82,    ,['citation-journal']," Estacio RO, Schrier RW. Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial.  American Journal of Cardiology 1998;82(9b):9r‐14r. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0002-9149(98)00750-4', 'https://scholar.google.com/scholar_lookup?title=Antihypertensive+therapy+in+type+2+diabetes:+implications+of+the+appropriate+blood+pressure+control+in+diabetes+(ABCD)+trial+&author=RO+Estacio&author=RW+Schrier&publication_year=1998&hl=en']",,https://doi.org/10.1016/S0002-9149(98)00750-4, Estacio 1998 {published data only}  ,included,CD008170-bbs2-0014,
CD008170-bib-0034,Fogari RZ. ,Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size, Clinical Cardiology ,2012,35,    ,['citation-journal'], Fogari RZ. Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size.  Clinical Cardiology 2012;35:359‐64. CENTRAL    Link to article     PubMed     Google Scholar     ,"['', 'https://doi.org/10.1002/clc.21994', 'https://www.ncbi.nlm.nih.gov/pubmed/22522403', 'https://scholar.google.com/scholar_lookup?title=Effect+of+telmisartan+on+paroxysmal+atrial+fibrillation+recurrence+in+hypertensive+patients+with+normal+or+increased+left+atrial+size+&author=RZ+Fogari&publication_year=2012&hl=en']",22522403,https://doi.org/10.1002/clc.21994, Fogari 2012 {published data only}  ,included,CD008170-bbs2-0015,
CD008170-bib-0035,"Gerritsen TA, Bak AA, Stolk RP, Jonker JJ, Grobbee DE. ",Effects of nitrendipine and enalapril on left ventricular mass in patients with non‐insulin‐dependent diabetes mellitus and hypertension, Journal of Hypertension ,1998,16,    ,['citation-journal']," Gerritsen TA, Bak AA, Stolk RP, Jonker JJ, Grobbee DE. Effects of nitrendipine and enalapril on left ventricular mass in patients with non‐insulin‐dependent diabetes mellitus and hypertension.  Journal of Hypertension 1998;16(5):689‐96. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/00004872-199816050-00017', 'https://www.ncbi.nlm.nih.gov/pubmed/9797181', 'https://scholar.google.com/scholar_lookup?title=Effects+of+nitrendipine+and+enalapril+on+left+ventricular+mass+in+patients+with+non‐insulin‐dependent+diabetes+mellitus+and+hypertension+&author=TA+Gerritsen&author=AA+Bak&author=RP+Stolk&author=JJ+Jonker&author=DE+Grobbee&publication_year=1998&hl=en']",9797181,https://doi.org/10.1097/00004872-199816050-00017, Gerritsen 1998 {published data only}  ,included,CD008170-bbs2-0016,
CD008170-bib-0036,"Gottdiener JS, Reda DJ, Williams DW, Materson BJ, Cushman W, Anderson RJ. ",Effect of single‐drug therapy on reduction of left atrial size in mild to moderate hypertension, Circulation ,1998,98,    ,['citation-journal']," Gottdiener JS, Reda DJ, Williams DW, Materson BJ, Cushman W, Anderson RJ. Effect of single‐drug therapy on reduction of left atrial size in mild to moderate hypertension.  Circulation 1998;98(2):140‐8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1161/01.CIR.98.2.140', 'https://www.ncbi.nlm.nih.gov/pubmed/9679720', 'https://scholar.google.com/scholar_lookup?title=Effect+of+single‐drug+therapy+on+reduction+of+left+atrial+size+in+mild+to+moderate+hypertension+&author=JS+Gottdiener&author=DJ+Reda&author=DW+Williams&author=BJ+Materson&author=W+Cushman&author=RJ+Anderson&publication_year=1998&hl=en']",9679720,https://doi.org/10.1161/01.CIR.98.2.140, Gottdiener 1998 {published data only}  ,included,CD008170-bbs2-0017,
CD008170-bib-0037,"Hajjar I, Hart M, Chen YL, Mack W, Milberg W, Chui H, et al. ",Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: a double‐blind randomized clinical trial, Archives of Internal Medicine ,2012,172,    ,['citation-journal']," Hajjar I, Hart M, Chen YL, Mack W, Milberg W, Chui H, et al. Effect of antihypertensive therapy on cognitive function in early executive cognitive impairment: a double‐blind randomized clinical trial.  Archives of Internal Medicine 2012;172(5):442‐4. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1001/archinternmed.2011.1391', 'https://www.ncbi.nlm.nih.gov/pubmed/22412114', 'https://scholar.google.com/scholar_lookup?title=Effect+of+antihypertensive+therapy+on+cognitive+function+in+early+executive+cognitive+impairment:+a+double‐blind+randomized+clinical+trial+&author=I+Hajjar&author=M+Hart&author=YL+Chen&author=W+Mack&author=W+Milberg&author=H+Chui&publication_year=2012&hl=en']",22412114,https://doi.org/10.1001/archinternmed.2011.1391, Hajjar 2013 {published data only}  ,included,CD008170-bbs2-0018,
CD008170-bib-0038,"Hajjar I, Hart M, Chen YL, Mack W, Novak V, Chui C, et al. ",Antihypertensive therapy and cerebral hemodynamics in executive mild cognitive impairment: results of a pilot randomized clinical trial, Journal of the American Geriatrics Society ,2013,61,    ,['citation-journal']," Hajjar I, Hart M, Chen YL, Mack W, Novak V, Chui C, et al. Antihypertensive therapy and cerebral hemodynamics in executive mild cognitive impairment: results of a pilot randomized clinical trial.  Journal of the American Geriatrics Society 2013;61(2):194‐201. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/jgs.12100', 'https://www.ncbi.nlm.nih.gov/pubmed/23350899', 'https://scholar.google.com/scholar_lookup?title=Antihypertensive+therapy+and+cerebral+hemodynamics+in+executive+mild+cognitive+impairment:+results+of+a+pilot+randomized+clinical+trial+&author=I+Hajjar&author=M+Hart&author=YL+Chen&author=W+Mack&author=V+Novak&author=C+Chui&publication_year=2013&hl=en']",23350899,https://doi.org/10.1111/jgs.12100, Hajjar 2013 {published data only}  ,included,CD008170-bbs2-0018,
CD008170-bib-0039,"Hauf‐Zachariou U, Widmann L, Zülsdorf B, Hennig M, Lang PD. ",A double‐blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia, European Journal of Clinical Pharmacology ,1993,45,    ,['citation-journal']," Hauf‐Zachariou U, Widmann L, Zülsdorf B, Hennig M, Lang PD. A double‐blind comparison of the effects of carvedilol and captopril on serum lipid concentrations in patients with mild to moderate essential hypertension and dyslipidaemia.  European Journal of Clinical Pharmacology 1993;45(2):95‐100. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1007/BF00315487', 'https://www.ncbi.nlm.nih.gov/pubmed/8223847', 'https://scholar.google.com/scholar_lookup?title=A+double‐blind+comparison+of+the+effects+of+carvedilol+and+captopril+on+serum+lipid+concentrations+in+patients+with+mild+to+moderate+essential+hypertension+and+dyslipidaemia+&author=U+Hauf‐Zachariou&author=L+Widmann&author=B+Zülsdorf&author=M+Hennig&author=PD+Lang&publication_year=1993&hl=en']",8223847,https://doi.org/10.1007/BF00315487, Hauf‐Zachariou 1993 {published data only}  ,included,CD008170-bbs2-0019,
CD008170-bib-0040,"Hayoz D, Zappe DH, Meyer MA, Baek I, Kandra A, Joly MP, et al. ",Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen, Journal of Clinical Hypertension ,2012,14,    ,['citation-journal']," Hayoz D, Zappe DH, Meyer MA, Baek I, Kandra A, Joly MP, et al. Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen.  Journal of Clinical Hypertension 2012;14(11):773‐8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/jch.12004', 'https://www.ncbi.nlm.nih.gov/pubmed/23126349', 'https://scholar.google.com/scholar_lookup?title=Changes+in+aortic+pulse+wave+velocity+in+hypertensive+postmenopausal+women:+comparison+between+a+calcium+channel+blocker+vs+angiotensin+receptor+blocker+regimen+&author=D+Hayoz&author=DH+Zappe&author=MA+Meyer&author=I+Baek&author=A+Kandra&author=MP+Joly&publication_year=2012&hl=en']",23126349,https://doi.org/10.1111/jch.12004, Hayoz 2012 {published data only}  ,included,CD008170-bbs2-0020,
CD008170-bib-0041,"Himmelmann A, Hansson L, Hansson BG, Hedstrand H, Skogström K, Ohrvik J, et al. ",Long‐term renal preservation in essential hypertension. Angiotensin converting enzyme inhibition is superior to beta‐blockade, American Journal of Hypertension ,1996,9,    ,['citation-journal']," Himmelmann A, Hansson L, Hansson BG, Hedstrand H, Skogström K, Ohrvik J, et al. Long‐term renal preservation in essential hypertension. Angiotensin converting enzyme inhibition is superior to beta‐blockade.  American Journal of Hypertension 1996;9(9):850‐3. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0895-7061(96)00176-8', 'https://www.ncbi.nlm.nih.gov/pubmed/8879340', 'https://scholar.google.com/scholar_lookup?title=Long‐term+renal+preservation+in+essential+hypertension.+Angiotensin+converting+enzyme+inhibition+is+superior+to+beta‐blockade+&author=A+Himmelmann&author=L+Hansson&author=BG+Hansson&author=H+Hedstrand&author=K+Skogström&author=J+Ohrvik&publication_year=1996&hl=en']",8879340,https://doi.org/10.1016/S0895-7061(96)00176-8, Himmelmann 1996 {published data only}  ,included,CD008170-bbs2-0021,
CD008170-bib-0042,"Hughes AD, Stanton AV, Jabbar AS, Chapman N, Martinez‐Perez ME, McG Thom SA. ",Effect of antihypertensive treatment on retinal microvascular changes in hypertension, Journal of Hypertension ,2008,26,    ,['citation-journal']," Hughes AD, Stanton AV, Jabbar AS, Chapman N, Martinez‐Perez ME, McG Thom SA. Effect of antihypertensive treatment on retinal microvascular changes in hypertension.  Journal of Hypertension 2008;26(8):1703‐7. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/HJH.0b013e328304b072', 'https://www.ncbi.nlm.nih.gov/pubmed/18622251', 'https://scholar.google.com/scholar_lookup?title=Effect+of+antihypertensive+treatment+on+retinal+microvascular+changes+in+hypertension&author=AD+Hughes&author=AV+Stanton&author=AS+Jabbar&author=N+Chapman&author=ME+Martinez‐Perez&author=SA+McGThom&publication_year=2008&hl=en']",18622251,https://doi.org/10.1097/HJH.0b013e328304b072, Hughes 2008 {published data only}  ,included,CD008170-bbs2-0022,
CD008170-bib-0043,"Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, et al. ",Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy, Annals of Internal Medicine ,2003,138,    ,['citation-journal']," Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, et al. Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.  Annals of Internal Medicine 2003;138(7):542‐9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.7326/0003-4819-138-7-200304010-00010', 'https://www.ncbi.nlm.nih.gov/pubmed/12667024', 'https://scholar.google.com/scholar_lookup?title=Cardiovascular+outcomes+in+the+Irbesartan+Diabetic+Nephropathy+Trial+of+patients+with+type+2+diabetes+and+overt+nephropathy+&author=T+Berl&author=LG+Hunsicker&author=JB+Lewis&author=MA+Pfeffer&author=JG+Porush&author=JL+Rouleau&publication_year=2003&hl=en']",12667024,https://doi.org/10.7326/0003-4819-138-7-200304010-00010, IDNT 2001 {published data only}  ,included,CD008170-bbs2-0023,
CD008170-bib-0044,"Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. ",Renoprotective effect of the angiotensin‐receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes, New England Journal of Medicine ,2001,345,    ,['citation-journal']," Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin‐receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.  New England Journal of Medicine 2001;345(12):851‐60. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1056/NEJMoa011303', 'https://scholar.google.com/scholar_lookup?title=Renoprotective+effect+of+the+angiotensin‐receptor+antagonist+irbesartan+in+patients+with+nephropathy+due+to+type+2+diabetes+&author=EJ+Lewis&author=LG+Hunsicker&author=WR+Clarke&author=T+Berl&author=MA+Pohl&author=JB+Lewis&publication_year=2001&hl=en']",,https://doi.org/10.1056/NEJMoa011303, IDNT 2001 {published data only}  ,included,CD008170-bbs2-0023,
CD008170-bib-0045,"Dahlöf B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, et al. ","The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group", American Journal of Hypertension ,1997,10,    ,['citation-journal']," Dahlöf B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, et al. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.  American Journal of Hypertension 1997;10(7 Pt 1):705‐13. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/9234823', 'https://scholar.google.com/scholar_lookup?title=The+Losartan+Intervention+For+Endpoint+reduction+(LIFE)+in+Hypertension+study:+rationale,+design,+and+methods.+The+LIFE+Study+Group+&author=B+Dahlöf&author=R+Devereux&author=U+Faire&author=F+Fyhrquist&author=T+Hedner&author=H+Ibsen&publication_year=1997&hl=en']",9234823,, LIFE 2002 {published data only}  ,included,CD008170-bbs2-0024,
CD008170-bib-0046,"Dahlöf B, Devereux RB, Julius S, Kjeldsen SE, Beevers G, de Faire U, et al. ",Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension, Hypertension ,1998,32,    ,['citation-journal']," Dahlöf B, Devereux RB, Julius S, Kjeldsen SE, Beevers G, de Faire U, et al. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.  Hypertension 1998;32(6):989‐97. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1161/01.HYP.32.6.989', 'https://www.ncbi.nlm.nih.gov/pubmed/9856962', 'https://scholar.google.com/scholar_lookup?title=Characteristics+of+9194+patients+with+left+ventricular+hypertrophy:+the+LIFE+study.+Losartan+Intervention+For+Endpoint+Reduction+in+Hypertension+&author=B+Dahlöf&author=RB+Devereux&author=S+Julius&author=SE+Kjeldsen&author=G+Beevers&author=U+Faire&publication_year=1998&hl=en']",9856962,https://doi.org/10.1161/01.HYP.32.6.989, LIFE 2002 {published data only}  ,included,CD008170-bbs2-0024,
CD008170-bib-0047,"Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. ",Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol, Lancet ,2002,359,    ,['citation-journal']," Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.  Lancet 2002;359(9311):995‐1003. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0140-6736(02)08089-3', 'https://www.ncbi.nlm.nih.gov/pubmed/11937178', 'https://scholar.google.com/scholar_lookup?title=Cardiovascular+morbidity+and+mortality+in+the+Losartan+Intervention+For+Endpoint+reduction+in+hypertension+study+(LIFE):+a+randomised+trial+against+atenolol+&author=B+Dahlöf&author=RB+Devereux&author=SE+Kjeldsen&author=S+Julius&author=G+Beevers&author=U+Faire&publication_year=2002&hl=en']",11937178,https://doi.org/10.1016/S0140-6736(02)08089-3, LIFE 2002 {published data only}  ,included,CD008170-bbs2-0024,
CD008170-bib-0048,"Devereux RB, Dahlöf B, Kjeldsen SE, Julius S, Aurup P, Beevers G, et al. ",Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial, Annals of Internal Medicine ,2003,139,    ,['citation-journal']," Devereux RB, Dahlöf B, Kjeldsen SE, Julius S, Aurup P, Beevers G, et al. Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.  Annals of Internal Medicine 2003;139(3):169‐77. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.7326/0003-4819-139-3-200308050-00006', 'https://www.ncbi.nlm.nih.gov/pubmed/12899584', 'https://scholar.google.com/scholar_lookup?title=Effects+of+losartan+or+atenolol+in+hypertensive+patients+without+clinically+evident+vascular+disease:+a+substudy+of+the+LIFE+randomized+trial+&author=RB+Devereux&author=B+Dahlöf&author=SE+Kjeldsen&author=S+Julius&author=P+Aurup&author=G+Beevers&publication_year=2003&hl=en']",12899584,https://doi.org/10.7326/0003-4819-139-3-200308050-00006, LIFE 2002 {published data only}  ,included,CD008170-bbs2-0024,
CD008170-bib-0049,"Fossum E, Moan A, Kjeldsen SE, Devereux RB, Julius S, Snapinn SM, et al. ",The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study, Journal of the American College of Cardiology ,2005,46,    ,['citation-journal']," Fossum E, Moan A, Kjeldsen SE, Devereux RB, Julius S, Snapinn SM, et al. The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.  Journal of the American College of Cardiology 2005;46(5):770‐5. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/j.jacc.2005.05.060', 'https://www.ncbi.nlm.nih.gov/pubmed/16139123', 'https://scholar.google.com/scholar_lookup?title=The+effect+of+losartan+versus+atenolol+on+cardiovascular+morbidity+and+mortality+in+patients+with+hypertension+taking+aspirin:+the+Losartan+Intervention+for+Endpoint+Reduction+in+hypertension+(LIFE)+study+&author=E+Fossum&author=A+Moan&author=SE+Kjeldsen&author=RB+Devereux&author=S+Julius&author=SM+Snapinn&publication_year=2005&hl=en']",16139123,https://doi.org/10.1016/j.jacc.2005.05.060, LIFE 2002 {published data only}  ,included,CD008170-bbs2-0024,
CD008170-bib-0050,"Franklin SS, Wachtell K, Papademetriou V, Olsen MH, Devereux RB, Fyhrquist F, et al. ",Cardiovascular morbidity and mortality in hypertensive patients with lower versus higher risk: a LIFE substudy, Hypertension ,2005,46,    ,['citation-journal']," Franklin SS, Wachtell K, Papademetriou V, Olsen MH, Devereux RB, Fyhrquist F, et al. Cardiovascular morbidity and mortality in hypertensive patients with lower versus higher risk: a LIFE substudy.  Hypertension 2005;46(3):492‐9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1161/01.HYP.0000179604.42845.8d', 'https://www.ncbi.nlm.nih.gov/pubmed/16116047', 'https://scholar.google.com/scholar_lookup?title=Cardiovascular+morbidity+and+mortality+in+hypertensive+patients+with+lower+versus+higher+risk:+a+LIFE+substudy+&author=SS+Franklin&author=K+Wachtell&author=V+Papademetriou&author=MH+Olsen&author=RB+Devereux&author=F+Fyhrquist&publication_year=2005&hl=en']",16116047,https://doi.org/10.1161/01.HYP.0000179604.42845.8d, LIFE 2002 {published data only}  ,included,CD008170-bbs2-0024,
CD008170-bib-0051,"Gerdts E, Franklin S, Rieck A, Papademetriou V, Wachtell K, Nieminen M, et al. ","Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study)", Blood Pressure ,2009,18,    ,['citation-journal']," Gerdts E, Franklin S, Rieck A, Papademetriou V, Wachtell K, Nieminen M, et al. Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study).  Blood Pressure 2009;18(4):180‐6. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1080/08037050903047202', 'https://www.ncbi.nlm.nih.gov/pubmed/19562573', 'https://scholar.google.com/scholar_lookup?title=Pulse+pressure,+left+ventricular+function+and+cardiovascular+events+during+antihypertensive+treatment+(the+LIFE+study)+&author=E+Gerdts&author=S+Franklin&author=A+Rieck&author=V+Papademetriou&author=K+Wachtell&author=M+Nieminen&publication_year=2009&hl=en']",19562573,https://doi.org/10.1080/08037050903047202, LIFE 2002 {published data only}  ,included,CD008170-bbs2-0024,
CD008170-bib-0052,"Julius S, Alderman MH, Beevers G, Dahlöf B, Devereux RB, Douglas JG, et al. ",Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study, Journal of the American College of Cardiology ,2004,43,    ,['citation-journal']," Julius S, Alderman MH, Beevers G, Dahlöf B, Devereux RB, Douglas JG, et al. Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study.  Journal of the American College of Cardiology 2004;43(6):1047‐55. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/j.jacc.2003.11.029', 'https://www.ncbi.nlm.nih.gov/pubmed/15028365', 'https://scholar.google.com/scholar_lookup?title=Cardiovascular+risk+reduction+in+hypertensive+black+patients+with+left+ventricular+hypertrophy:+the+LIFE+study+&author=S+Julius&author=MH+Alderman&author=G+Beevers&author=B+Dahlöf&author=RB+Devereux&author=JG+Douglas&publication_year=2004&hl=en']",15028365,https://doi.org/10.1016/j.jacc.2003.11.029, LIFE 2002 {published data only}  ,included,CD008170-bbs2-0024,
CD008170-bib-0053,"Kizer JR, Dahlof B, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. ",Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study, Hypertension ,2005,45,    ,['citation-journal']," Kizer JR, Dahlof B, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study.  Hypertension 2005;45(1):46‐52. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1161/01.HYP.0000151324.05355.1c', 'https://www.ncbi.nlm.nih.gov/pubmed/15583076', 'https://scholar.google.com/scholar_lookup?title=Stroke+reduction+in+hypertensive+adults+with+cardiac+hypertrophy+randomized+to+losartan+versus+atenolol:+the+Losartan+Intervention+For+Endpoint+reduction+in+hypertension+study+&author=JR+Kizer&author=B+Dahlof&author=SE+Kjeldsen&author=S+Julius&author=G+Beevers&author=U+Faire&publication_year=2005&hl=en']",15583076,https://doi.org/10.1161/01.HYP.0000151324.05355.1c, LIFE 2002 {published data only}  ,included,CD008170-bbs2-0024,
CD008170-bib-0054,"Kjeldsen SE, Lyle PA, Kizer JR, Dahlof B, Devereux RB, Julius S, et al. ",The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study, Journal of Clinical Hypertension ,2005,7,    ,['citation-journal']," Kjeldsen SE, Lyle PA, Kizer JR, Dahlof B, Devereux RB, Julius S, et al. The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study.  Journal of Clinical Hypertension 2005;7(3):152‐8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/j.1524-6175.2005.04254.x', 'https://www.ncbi.nlm.nih.gov/pubmed/15785156', 'https://scholar.google.com/scholar_lookup?title=The+effects+of+losartan+compared+to+atenolol+on+stroke+in+patients+with+isolated+systolic+hypertension+and+left+ventricular+hypertrophy.+The+LIFE+study+&author=SE+Kjeldsen&author=PA+Lyle&author=JR+Kizer&author=B+Dahlof&author=RB+Devereux&author=S+Julius&publication_year=2005&hl=en']",15785156,https://doi.org/10.1111/j.1524-6175.2005.04254.x, LIFE 2002 {published data only}  ,included,CD008170-bbs2-0024,
CD008170-bib-0055,"Lindholm LH, Ibsen H, Dahlöf B, Devereux RB, Beevers G, de Faire U, et al. ",Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol, Lancet ,2002,359,    ,['citation-journal']," Lindholm LH, Ibsen H, Dahlöf B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.  Lancet 2002;359(9311):1004‐10. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0140-6736(02)08090-X', 'https://www.ncbi.nlm.nih.gov/pubmed/11937179', 'https://scholar.google.com/scholar_lookup?title=Cardiovascular+morbidity+and+mortality+in+patients+with+diabetes+in+the+Losartan+Intervention+For+Endpoint+reduction+in+hypertension+study+(LIFE):+a+randomised+trial+against+atenolol+&author=LH+Lindholm&author=H+Ibsen&author=B+Dahlöf&author=RB+Devereux&author=G+Beevers&author=U+Faire&publication_year=2002&hl=en']",11937179,https://doi.org/10.1016/S0140-6736(02)08090-X, LIFE 2002 {published data only}  ,included,CD008170-bbs2-0024,
CD008170-bib-0058,Okin PM. ,Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients, Journal of Electrocardiology ,2009,42,    ,['citation-journal'], Okin PM. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.  Journal of Electrocardiology 2009;42(6):584‐8. CENTRAL    Link to article     PubMed     Google Scholar     ,"['', 'https://doi.org/10.1016/j.jelectrocard.2009.06.020', 'https://www.ncbi.nlm.nih.gov/pubmed/19631946', 'https://scholar.google.com/scholar_lookup?title=Serial+evaluation+of+electrocardiographic+left+ventricular+hypertrophy+for+prediction+of+risk+in+hypertensive+patients+&author=PM+Okin&publication_year=2009&hl=en']",19631946,https://doi.org/10.1016/j.jelectrocard.2009.06.020, LIFE 2002 {published data only}  ,included,CD008170-bbs2-0024,
CD008170-bib-0056,"Okin PM, Bang CN, Wachtell K, Hille DA, Kjeldsen SE, Dahlof B, et al. ",Relationship of sudden cardiac death to new‐onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy, Circulation: Arrhythmia and Electrophysiology ,2013,6,    ,['citation-journal']," Okin PM, Bang CN, Wachtell K, Hille DA, Kjeldsen SE, Dahlof B, et al. Relationship of sudden cardiac death to new‐onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy.  Circulation: Arrhythmia and Electrophysiology 2013;6(2):243‐51. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/23403268', 'https://scholar.google.com/scholar_lookup?title=Relationship+of+sudden+cardiac+death+to+new‐onset+atrial+fibrillation+in+hypertensive+patients+with+left+ventricular+hypertrophy+&author=PM+Okin&author=CN+Bang&author=K+Wachtell&author=DA+Hille&author=SE+Kjeldsen&author=B+Dahlof&publication_year=2013&hl=en']",23403268,, LIFE 2002 {published data only}  ,included,CD008170-bbs2-0024,
CD008170-bib-0057,"Okin PM, Hille DA, Kjeldsen SE, Lindholm LH, Edelman JM, Dahlof B, et al. ",Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients, American Journal of Hypertension ,2010,23,    ,['citation-journal']," Okin PM, Hille DA, Kjeldsen SE, Lindholm LH, Edelman JM, Dahlof B, et al. Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients.  American Journal of Hypertension 2010;23(7):786‐93. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1038/ajh.2010.65', 'https://www.ncbi.nlm.nih.gov/pubmed/20395941', 'https://scholar.google.com/scholar_lookup?title=Greater+regression+of+electrocardiographic+left+ventricular+hypertrophy+during+hydrochlorothiazide+therapy+in+hypertensive+patients+&author=PM+Okin&author=DA+Hille&author=SE+Kjeldsen&author=LH+Lindholm&author=JM+Edelman&author=B+Dahlof&publication_year=2010&hl=en']",20395941,https://doi.org/10.1038/ajh.2010.65, LIFE 2002 {published data only}  ,included,CD008170-bbs2-0024,
CD008170-bib-0059,"Olsen MH, Wachtell K, Beevers G, Dahlof B, de Simone G, Devereux RB, et al. ",Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study, Journal of Hypertension ,2009,27,    ,['citation-journal']," Olsen MH, Wachtell K, Beevers G, Dahlof B, de Simone G, Devereux RB, et al. Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.  Journal of Hypertension 2009;27(3):567‐74. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/HJH.0b013e32831daf96', 'https://www.ncbi.nlm.nih.gov/pubmed/19262226', 'https://scholar.google.com/scholar_lookup?title=Effects+of+losartan+compared+with+atenolol+on+lipids+in+patients+with+hypertension+and+left+ventricular+hypertrophy:+the+Losartan+Intervention+For+Endpoint+reduction+in+hypertension+study+&author=MH+Olsen&author=K+Wachtell&author=G+Beevers&author=B+Dahlof&author=G+Simone&author=RB+Devereux&publication_year=2009&hl=en']",19262226,https://doi.org/10.1097/HJH.0b013e32831daf96, LIFE 2002 {published data only}  ,included,CD008170-bbs2-0024,
CD008170-bib-0060,"Os I, Franco V, Kjeldsen SE, Manhem K, Devereux RB, Gerdts E, et al. ",Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study, Hypertension ,2008,51,    ,['citation-journal']," Os I, Franco V, Kjeldsen SE, Manhem K, Devereux RB, Gerdts E, et al. Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study.  Hypertension 2008;51(4):1103‐8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1161/HYPERTENSIONAHA.107.105296', 'https://www.ncbi.nlm.nih.gov/pubmed/18259029', 'https://scholar.google.com/scholar_lookup?title=Effects+of+losartan+in+women+with+hypertension+and+left+ventricular+hypertrophy:+results+from+the+Losartan+Intervention+for+Endpoint+Reduction+in+Hypertension+Study+&author=I+Os&author=V+Franco&author=SE+Kjeldsen&author=K+Manhem&author=RB+Devereux&author=E+Gerdts&publication_year=2008&hl=en']",18259029,https://doi.org/10.1161/HYPERTENSIONAHA.107.105296, LIFE 2002 {published data only}  ,included,CD008170-bbs2-0024,
CD008170-bib-0062,"Malmqvist K, Kahan T, Edner M, Bergfeldt L. ",Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA), American Journal of Cardiology ,2002,90,    ,['citation-journal']," Malmqvist K, Kahan T, Edner M, Bergfeldt L. Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA).  American Journal of Cardiology 2002;90(10):1107‐12. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/S0002-9149(02)02777-7', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+actions+of+irbesartan+versus+atenolol+on+cardiac+repolarization+in+hypertensive+left+ventricular+hypertrophy:+results+from+the+Swedish+Irbesartan+Left+Ventricular+Hypertrophy+Investigation+Versus+Atenolol+(SILVHIA)+&author=K+Malmqvist&author=T+Kahan&author=M+Edner&author=L+Bergfeldt&publication_year=2002&hl=en']",,https://doi.org/10.1016/S0002-9149(02)02777-7, Malmqvist 2002 {published data only}  ,included,CD008170-bbs2-0025,
CD008170-bib-0061,"Malmqvist K, Öhman KP, Lind L, Nyström F, Kahan T. ",Long‐term effects of irbesartan and atenolol on the renin‐angiotensin‐aldosterone system in human primary hypertension: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA), Journal of Cardiovascular Pharmacology ,2003,42,    ,['citation-journal']," Malmqvist K, Öhman KP, Lind L, Nyström F, Kahan T. Long‐term effects of irbesartan and atenolol on the renin‐angiotensin‐aldosterone system in human primary hypertension: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).  Journal of Cardiovascular Pharmacology 2003;42:719‐26. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/00005344-200312000-00005', 'https://www.ncbi.nlm.nih.gov/pubmed/14639093', 'https://scholar.google.com/scholar_lookup?title=Long‐term+effects+of+irbesartan+and+atenolol+on+the+renin‐angiotensin‐aldosterone+system+in+human+primary+hypertension:+the+Swedish+Irbesartan+Left+Ventricular+Hypertrophy+Investigation+versus+Atenolol+(SILVHIA)+&author=K+Malmqvist&author=KP+Öhman&author=L+Lind&author=F+Nyström&author=T+Kahan&publication_year=2003&hl=en']",14639093,https://doi.org/10.1097/00005344-200312000-00005, Malmqvist 2002 {published data only}  ,included,CD008170-bbs2-0025,
CD008170-bib-0063,"Mortsell D, Malmqvist K, Held C, Kahan T. ",Irbesartan reduces common carotid artery intima‐media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study, Journal of Internal Medicine ,2007,261,    ,['citation-journal']," Mortsell D, Malmqvist K, Held C, Kahan T. Irbesartan reduces common carotid artery intima‐media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study.  Journal of Internal Medicine 2007;261(5):472‐9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/j.1365-2796.2007.01775.x', 'https://www.ncbi.nlm.nih.gov/pubmed/17444886', 'https://scholar.google.com/scholar_lookup?title=Irbesartan+reduces+common+carotid+artery+intima‐media+thickness+in+hypertensive+patients+when+compared+with+atenolol:+the+Swedish+Irbesartan+Left+Ventricular+Hypertrophy+Investigation+versus+Atenolol+(SILVHIA)+study+&author=D+Mortsell&author=K+Malmqvist&author=C+Held&author=T+Kahan&publication_year=2007&hl=en']",17444886,https://doi.org/10.1111/j.1365-2796.2007.01775.x, Malmqvist 2002 {published data only}  ,included,CD008170-bbs2-0025,
CD008170-bib-0064,"Marre M, Puig JG, Kokot F, Fernandez M, Jermendy G, Opie L, et al. ",Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: The NESTOR* study, Journal of Hypertension ,2004,22,    ,['citation-journal']," Marre M, Puig JG, Kokot F, Fernandez M, Jermendy G, Opie L, et al. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: The NESTOR* study.  Journal of Hypertension 2004;22(8):1613‐22. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/01.hjh.0000133733.32125.09', 'https://www.ncbi.nlm.nih.gov/pubmed/15257186', 'https://scholar.google.com/scholar_lookup?title=Equivalence+of+indapamide+SR+and+enalapril+on+microalbuminuria+reduction+in+hypertensive+patients+with+type+2+diabetes:+The+NESTOR*+study+&author=M+Marre&author=JG+Puig&author=F+Kokot&author=M+Fernandez&author=G+Jermendy&author=L+Opie&publication_year=2004&hl=en']",15257186,https://doi.org/10.1097/01.hjh.0000133733.32125.09, NESTOR 2015 {published data only}  ,included,CD008170-bbs2-0026,
CD008170-bib-0065,"Zhang Y, Agnoletti D, Wang JG, Xu Y, Safar ME. ",Natriuresis and blood pressure reduction in hypertensive patients with diabetes mellitus: the NESTOR study, Journal of the American Society of Hypertension ,2015,9,    ,['citation-journal']," Zhang Y, Agnoletti D, Wang JG, Xu Y, Safar ME. Natriuresis and blood pressure reduction in hypertensive patients with diabetes mellitus: the NESTOR study.  Journal of the American Society of Hypertension 2015;9(1):21‐8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/j.jash.2014.10.003', 'https://www.ncbi.nlm.nih.gov/pubmed/25539895', 'https://scholar.google.com/scholar_lookup?title=Natriuresis+and+blood+pressure+reduction+in+hypertensive+patients+with+diabetes+mellitus:+the+NESTOR+study+&author=Y+Zhang&author=D+Agnoletti&author=JG+Wang&author=Y+Xu&author=ME+Safar&publication_year=2015&hl=en']",25539895,https://doi.org/10.1016/j.jash.2014.10.003, NESTOR 2015 {published data only}  ,included,CD008170-bbs2-0026,
CD008170-bib-0066,"Ostman J, Asplund K, Bystedt T, Dahlöf B, Jern S, Kjellström T, et al. ","Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non‐insulin‐dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group", Journal of Internal Medicine ,1998,244,    ,['citation-journal']," Ostman J, Asplund K, Bystedt T, Dahlöf B, Jern S, Kjellström T, et al. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non‐insulin‐dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.  Journal of Internal Medicine 1998;244(2):95‐107. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1046/j.1365-2796.1998.00319.x', 'https://www.ncbi.nlm.nih.gov/pubmed/10095796', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+effects+of+quinapril+and+metoprolol+on+glycaemic+control,+serum+lipids,+blood+pressure,+albuminuria+and+quality+of+life+in+non‐insulin‐dependent+diabetes+mellitus+patients+with+hypertension.+Swedish+Quinapril+Group+&author=J+Ostman&author=K+Asplund&author=T+Bystedt&author=B+Dahlöf&author=S+Jern&author=T+Kjellström&publication_year=1998&hl=en']",10095796,https://doi.org/10.1046/j.1365-2796.1998.00319.x, Ostman 1998 {published data only}  ,included,CD008170-bbs2-0027,
CD008170-bib-0067,"Parrinello G, Paterna S, Torres D, Di Pasquale P, Mezzero M, La Rocca G, et al. ","One‐year renal and cardiac effects of bisoprolol versus losartan in recently diagnosed hypertensive patients: a randomized, double‐blind study", Clinical Drug Investigation ,2009,29,    ,['citation-journal']," Parrinello G, Paterna S, Torres D, Di Pasquale P, Mezzero M, La Rocca G, et al. One‐year renal and cardiac effects of bisoprolol versus losartan in recently diagnosed hypertensive patients: a randomized, double‐blind study.  Clinical Drug Investigation 2009;29(9):591‐600. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.2165/11315250-000000000-00000', 'https://www.ncbi.nlm.nih.gov/pubmed/19663521', 'https://scholar.google.com/scholar_lookup?title=One‐year+renal+and+cardiac+effects+of+bisoprolol+versus+losartan+in+recently+diagnosed+hypertensive+patients:+a+randomized,+double‐blind+study+&author=G+Parrinello&author=S+Paterna&author=D+Torres&author=P+Pasquale&author=M+Mezzero&author=G+Rocca&publication_year=2009&hl=en']",19663521,https://doi.org/10.2165/11315250-000000000-00000, Parrinello 2009 {published data only}  ,included,CD008170-bbs2-0028,
CD008170-bib-0068,"Pedersen EB, Bech JN, Nielsen CB, Kornerup HJ, Hansen HE, Spencer ES, et al. ","A comparison of the effect of ramipril, felodipine and placebo on glomerular filtration rate, albuminuria, blood pressure and vasoactive hormones in chronic glomerulonephritis. A randomized, prospective, double‐blind, placebo‐controlled study over two years", Scandinavian Journal of Clinical & Laboratory Investigation ,1997,57,    ,['citation-journal']," Pedersen EB, Bech JN, Nielsen CB, Kornerup HJ, Hansen HE, Spencer ES, et al. A comparison of the effect of ramipril, felodipine and placebo on glomerular filtration rate, albuminuria, blood pressure and vasoactive hormones in chronic glomerulonephritis. A randomized, prospective, double‐blind, placebo‐controlled study over two years.  Scandinavian Journal of Clinical & Laboratory Investigation 1997;57(8):673‐81. CENTRAL    Google Scholar     ","['', 'https://scholar.google.com/scholar_lookup?title=A+comparison+of+the+effect+of+ramipril,+felodipine+and+placebo+on+glomerular+filtration+rate,+albuminuria,+blood+pressure+and+vasoactive+hormones+in+chronic+glomerulonephritis.+A+randomized,+prospective,+double‐blind,+placebo‐controlled+study+over+two+years+&author=EB+Pedersen&author=JN+Bech&author=CB+Nielsen&author=HJ+Kornerup&author=HE+Hansen&author=ES+Spencer&publication_year=1997&hl=en']",,, Pedersen 1997 {published data only}  ,included,CD008170-bbs2-0029,
CD008170-bib-0069,"Petersen LJ, Petersen JR, Talleruphuus U, Moller ML, Ladefoged SD, Mehlsen J. ",A randomized and double‐blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension, Clinical Nephrology ,2001,55,    ,['citation-journal']," Petersen LJ, Petersen JR, Talleruphuus U, Moller ML, Ladefoged SD, Mehlsen J. A randomized and double‐blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.  Clinical Nephrology 2001;55:375‐83. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/11393383', 'https://scholar.google.com/scholar_lookup?title=A+randomized+and+double‐blind+comparison+of+isradipine+and+spirapril+as+monotherapy+and+in+combination+on+the+decline+in+renal+function+in+patients+with+chronic+renal+failure+and+hypertension+&author=LJ+Petersen&author=JR+Petersen&author=U+Talleruphuus&author=ML+Moller&author=SD+Ladefoged&author=J+Mehlsen&publication_year=2001&hl=en']",11393383,, Petersen 2001 {published data only}  ,included,CD008170-bbs2-0030,
CD008170-bib-0070,"Roman MJ, Alderman MH, Pickering TG, Pini R, Keating JO, Sealey JE, et al. ","Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy", American Journal of Hypertension ,1998,11,    ,['citation-journal']," Roman MJ, Alderman MH, Pickering TG, Pini R, Keating JO, Sealey JE, et al. Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy.  American Journal of Hypertension 1998;11(4 Pt 1):387‐96. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0895-7061(97)00492-5', 'https://www.ncbi.nlm.nih.gov/pubmed/9607375', 'https://scholar.google.com/scholar_lookup?title=Differential+effects+of+angiotensin+converting+enzyme+inhibition+and+diuretic+therapy+on+reductions+in+ambulatory+blood+pressure,+left+ventricular+mass,+and+vascular+hypertrophy+&author=MJ+Roman&author=MH+Alderman&author=TG+Pickering&author=R+Pini&author=JO+Keating&author=JE+Sealey&publication_year=1998&hl=en']",9607375,https://doi.org/10.1016/S0895-7061(97)00492-5, Roman 1998 {published data only}  ,included,CD008170-bbs2-0031,
CD008170-bib-0071,"Schiffrin EL, Deng LY, Larochelle P. ",Effects of a beta‐blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension, Hypertension ,1994,23,    ,['citation-journal']," Schiffrin EL, Deng LY, Larochelle P. Effects of a beta‐blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension.  Hypertension 1994;23(1):83‐91. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1161/01.HYP.23.1.83', 'https://www.ncbi.nlm.nih.gov/pubmed/8282334', 'https://scholar.google.com/scholar_lookup?title=Effects+of+a+beta‐blocker+or+a+converting+enzyme+inhibitor+on+resistance+arteries+in+essential+hypertension+&author=EL+Schiffrin&author=LY+Deng&author=P+Larochelle&publication_year=1994&hl=en']",8282334,https://doi.org/10.1161/01.HYP.23.1.83, Schiffrin 1994 {published data only}  ,included,CD008170-bbs2-0032,
CD008170-bib-0072,"Schmieder RE, Philipp T, Guerediaga J, Gorostidi M, Smith B, Weissbach N, et al. ","Long‐term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12‐month randomized, double‐blind comparator trial with hydrochlorothiazide", Circulation ,2009,119,    ,['citation-journal']," Schmieder RE, Philipp T, Guerediaga J, Gorostidi M, Smith B, Weissbach N, et al. Long‐term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12‐month randomized, double‐blind comparator trial with hydrochlorothiazide.  Circulation 2009;119(3):417‐25. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1161/CIRCULATIONAHA.107.750745', 'https://www.ncbi.nlm.nih.gov/pubmed/19139391', 'https://scholar.google.com/scholar_lookup?title=Long‐term+antihypertensive+efficacy+and+safety+of+the+oral+direct+renin+inhibitor+aliskiren:+a+12‐month+randomized,+double‐blind+comparator+trial+with+hydrochlorothiazide+&author=RE+Schmieder&author=T+Philipp&author=J+Guerediaga&author=M+Gorostidi&author=B+Smith&author=N+Weissbach&publication_year=2009&hl=en']",19139391,https://doi.org/10.1161/CIRCULATIONAHA.107.750745, Schmieder 2009 {published data only}  ,included,CD008170-bbs2-0033,
CD008170-bib-0073,"Schneider MP, Klingbeil AU, Delles C, Ludwig M, Kolloch RE, Krekler M, et al. ",Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project, Hypertension ,2004,44,    ,['citation-journal']," Schneider MP, Klingbeil AU, Delles C, Ludwig M, Kolloch RE, Krekler M, et al. Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project.  Hypertension 2004;44(1):61‐6. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1161/01.HYP.0000133249.28773.d7', 'https://www.ncbi.nlm.nih.gov/pubmed/15184349', 'https://scholar.google.com/scholar_lookup?title=Effect+of+irbesartan+versus+atenolol+on+left+ventricular+mass+and+voltage:+results+of+the+CardioVascular+Irbesartan+Project+&author=MP+Schneider&author=AU+Klingbeil&author=C+Delles&author=M+Ludwig&author=RE+Kolloch&author=M+Krekler&publication_year=2004&hl=en']",15184349,https://doi.org/10.1161/01.HYP.0000133249.28773.d7, Schneider 2004 {published data only}  ,included,CD008170-bbs2-0034,
CD008170-bib-0074,"Schram MT, van Ittersum FJ, Spoelstra‐de Man A, van Dijk RA, Schalkwijk CG, Ijzerman RG, et al. ","Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double‐blind, randomized clinical trial", Journal of Human Hypertension ,2005,19,    ,['citation-journal']," Schram MT, van Ittersum FJ, Spoelstra‐de Man A, van Dijk RA, Schalkwijk CG, Ijzerman RG, et al. Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double‐blind, randomized clinical trial.  Journal of Human Hypertension 2005;19(6):429‐37. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/15647778', 'https://scholar.google.com/scholar_lookup?title=Aggressive+antihypertensive+therapy+based+on+hydrochlorothiazide,+candesartan+or+lisinopril+as+initial+choice+in+hypertensive+type+II+diabetic+individuals:+effects+on+albumin+excretion,+endothelial+function+and+inflammation+in+a+double‐blind,+randomized+clinical+trial+&author=MT+Schram&author=FJ+Ittersum&author=A+Spoelstra‐deMan&author=RA+Dijk&author=CG+Schalkwijk&author=RG+Ijzerman&publication_year=2005&hl=en']",15647778,, Schram 2005 {published data only}  ,included,CD008170-bbs2-0035,
CD008170-bib-0075,"Seedat YK, Randeree IG. ","Antihypertensive effect and tolerability of perindopril in Indian hypertensive and type 2 diabetic patients: 1‐year randomised, double‐blind, parallel study vs atenolol", Clinical Drug Investigation ,1998,16,    ,['citation-journal']," Seedat YK, Randeree IG. Antihypertensive effect and tolerability of perindopril in Indian hypertensive and type 2 diabetic patients: 1‐year randomised, double‐blind, parallel study vs atenolol.  Clinical Drug Investigation 1998;16(3):229‐240. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.2165/00044011-199816030-00007', 'https://www.ncbi.nlm.nih.gov/pubmed/18370544', 'https://scholar.google.com/scholar_lookup?title=Antihypertensive+effect+and+tolerability+of+perindopril+in+Indian+hypertensive+and+type+2+diabetic+patients:+1‐year+randomised,+double‐blind,+parallel+study+vs+atenolol+&author=YK+Seedat&author=IG+Randeree&publication_year=1998&hl=en']",18370544,https://doi.org/10.2165/00044011-199816030-00007, Seedat 1998 {published data only}  ,included,CD008170-bbs2-0036,
CD008170-bib-0076,"Malmqvist K, Kahan T, Edner M, Hagg A, Lind L, Muller‐Brunotte R, et al. ",Regression of left ventricular hypertrophy in human hypertension with irbesartan, Journal of Hypertension ,2001,19,    ,['citation-journal']," Malmqvist K, Kahan T, Edner M, Hagg A, Lind L, Muller‐Brunotte R, et al. Regression of left ventricular hypertrophy in human hypertension with irbesartan.  Journal of Hypertension 2001;19(6):1167‐76. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/00004872-200106000-00023', 'https://www.ncbi.nlm.nih.gov/pubmed/11403367', 'https://scholar.google.com/scholar_lookup?title=Regression+of+left+ventricular+hypertrophy+in+human+hypertension+with+irbesartan&author=K+Malmqvist&author=T+Kahan&author=M+Edner&author=A+Hagg&author=L+Lind&author=R+Muller‐Brunotte&publication_year=2001&hl=en']",11403367,https://doi.org/10.1097/00004872-200106000-00023, SILVHIA 2001 {published data only}  ,included,CD008170-bbs2-0037,
CD008170-bib-0077,"Sørensen VB, Rossing P, Tarnow L, Parving H, Nørgaard T, Kastrup J. ",Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive type I diabetes patients with nephropathy, Clinical Science ,1998,95,    ,['citation-journal']," Sørensen VB, Rossing P, Tarnow L, Parving H, Nørgaard T, Kastrup J. Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive type I diabetes patients with nephropathy.  Clinical Science 1998;95(6):709‐17. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1042/cs0950709', 'https://www.ncbi.nlm.nih.gov/pubmed/9831696', 'https://scholar.google.com/scholar_lookup?title=Effects+of+nisoldipine+and+lisinopril+on+microvascular+dysfunction+in+hypertensive+type+I+diabetes+patients+with+nephropathy+&author=VB+Sørensen&author=P+Rossing&author=L+Tarnow&author=H+Parving&author=T+Nørgaard&author=J+Kastrup&publication_year=1998&hl=en']",9831696,https://doi.org/10.1042/cs0950709, Sørensen 1998 {published data only}  ,included,CD008170-bbs2-0038,
CD008170-bib-0078,"Tarnow L, Sato A, Ali S, Rossing P, Nielsen FS, Parving HH. ",Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy, Diabetes Care ,1999,22,    ,['citation-journal']," Tarnow L, Sato A, Ali S, Rossing P, Nielsen FS, Parving HH. Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy.  Diabetes Care 1999;22(3):491‐4. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.2337/diacare.22.3.491', 'https://www.ncbi.nlm.nih.gov/pubmed/10097934', 'https://scholar.google.com/scholar_lookup?title=Effects+of+nisoldipine+and+lisinopril+on+left+ventricular+mass+and+function+in+diabetic+nephropathy+&author=L+Tarnow&author=A+Sato&author=S+Ali&author=P+Rossing&author=FS+Nielsen&author=HH+Parving&publication_year=1999&hl=en']",10097934,https://doi.org/10.2337/diacare.22.3.491, Tarnow 1999 {published data only}  ,included,CD008170-bbs2-0039,
CD008170-bib-0079,"Tedesco MA, Ratti G, Mennella S, Manzo G, Grieco M, Rainone AC, et al. ",Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients, American Journal of Hypertension ,1999,12,    ,['citation-journal']," Tedesco MA, Ratti G, Mennella S, Manzo G, Grieco M, Rainone AC, et al. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients.  American Journal of Hypertension 1999;12(11 Pt 1):1130‐4. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0895-7061(99)00156-9', 'https://www.ncbi.nlm.nih.gov/pubmed/10604491', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+losartan+and+hydrochlorothiazide+on+cognitive+function+and+quality+of+life+in+hypertensive+patients+&author=MA+Tedesco&author=G+Ratti&author=S+Mennella&author=G+Manzo&author=M+Grieco&author=AC+Rainone&publication_year=1999&hl=en']",10604491,https://doi.org/10.1016/S0895-7061(99)00156-9, Tedesco 1999 {published data only}  ,included,CD008170-bbs2-0040,
CD008170-bib-0080,"Terpstra WF, May JF, Smit AJ, Graeff PA, Meyboom‐de Jong B, Crijns HJ. ","Effects of amlodipine and lisinopril on intima‐media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial)", Journal of Hypertension ,2004,22,    ,['citation-journal']," Terpstra WF, May JF, Smit AJ, Graeff PA, Meyboom‐de Jong B, Crijns HJ. Effects of amlodipine and lisinopril on intima‐media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial).  Journal of Hypertension 2004;22(7):1309‐16. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/01.hjh.0000125412.50839.b5', 'https://www.ncbi.nlm.nih.gov/pubmed/15201546', 'https://scholar.google.com/scholar_lookup?title=Effects+of+amlodipine+and+lisinopril+on+intima‐media+thickness+in+previously+untreated,+elderly+hypertensive+patients+(the+ELVERA+trial)+&author=WF+Terpstra&author=JF+May&author=AJ+Smit&author=PA+Graeff&author=B+Meyboom‐deJong&author=HJ+Crijns&publication_year=2004&hl=en']",15201546,https://doi.org/10.1097/01.hjh.0000125412.50839.b5, Terpstra 2004 {published data only}  ,included,CD008170-bbs2-0041,
CD008170-bib-0081,"Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, et al. ",Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group, JAMA ,1993,270,    ,['citation-journal']," Neaton JD, Grimm RH, Prineas RJ, Stamler J, Grandits GA, Elmer PJ, et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group.  JAMA 1993;270(6):713‐24. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1001/jama.1993.03510060059034', 'https://www.ncbi.nlm.nih.gov/pubmed/8336373', 'https://scholar.google.com/scholar_lookup?title=Treatment+of+Mild+Hypertension+Study.+Final+results.+Treatment+of+Mild+Hypertension+Study+Research+Group+&author=JD+Neaton&author=RH+Grimm&author=RJ+Prineas&author=J+Stamler&author=GA+Grandits&author=PJ+Elmer&publication_year=1993&hl=en']",8336373,https://doi.org/10.1001/jama.1993.03510060059034, TOHMS 1993 {published data only}  ,included,CD008170-bbs2-0042,
CD008170-bib-0082,"Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. ",Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial, Lancet ,2004,363,    ,['citation-journal']," Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.  Lancet 2004;363(9426):2022‐31. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0140-6736(04)16451-9', 'https://www.ncbi.nlm.nih.gov/pubmed/15207952', 'https://scholar.google.com/scholar_lookup?title=Outcomes+in+hypertensive+patients+at+high+cardiovascular+risk+treated+with+regimens+based+on+valsartan+or+amlodipine:+the+VALUE+randomised+trial+&author=S+Julius&author=SE+Kjeldsen&author=M+Weber&author=HR+Brunner&author=S+Ekman&author=L+Hansson&publication_year=2004&hl=en']",15207952,https://doi.org/10.1016/S0140-6736(04)16451-9, VALUE 2004 {published data only}  ,included,CD008170-bbs2-0043,
CD008170-bib-0083,"Julius S, Weber MA, Kjeldsen SE, McInnes GT, Zanchetti A, Brunner HR, et al. ",The Valsartan Antihypertensive Long‐Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy, Hypertension ,2006,48,    ,['citation-journal']," Julius S, Weber MA, Kjeldsen SE, McInnes GT, Zanchetti A, Brunner HR, et al. The Valsartan Antihypertensive Long‐Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy.  Hypertension 2006;48(3):385‐91. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1161/01.HYP.0000236119.96301.f2', 'https://www.ncbi.nlm.nih.gov/pubmed/16864741', 'https://scholar.google.com/scholar_lookup?title=The+Valsartan+Antihypertensive+Long‐Term+Use+Evaluation+(VALUE)+trial:+outcomes+in+patients+receiving+monotherapy+&author=S+Julius&author=MA+Weber&author=SE+Kjeldsen&author=GT+McInnes&author=A+Zanchetti&author=HR+Brunner&publication_year=2006&hl=en']",16864741,https://doi.org/10.1161/01.HYP.0000236119.96301.f2, VALUE 2004 {published data only}  ,included,CD008170-bbs2-0043,
CD008170-bib-0084,"Mann J, Julius S. ",The Valsartan Antihypertensive Long‐term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design, Blood Pressure ,1998,7,    ,['citation-journal']," Mann J, Julius S. The Valsartan Antihypertensive Long‐term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design.  Blood Pressure 1998;7(3):176‐83. CENTRAL    PubMed     Google Scholar     ","['', 'https://www.ncbi.nlm.nih.gov/pubmed/9758088', 'https://scholar.google.com/scholar_lookup?title=The+Valsartan+Antihypertensive+Long‐term+Use+Evaluation+(VALUE)+trial+of+cardiovascular+events+in+hypertension.+Rationale+and+design+&author=J+Mann&author=S+Julius&publication_year=1998&hl=en']",9758088,, VALUE 2004 {published data only}  ,included,CD008170-bbs2-0043,
CD008170-bib-0085,"Sandset E, Krarup LH, Berge E, Kjeldsen SE, Julius S, Holzhauer B. ","Predictors of stroke recurrence in high‐risk, hypertensive patients", Journal of Hypertension ,2010,28,    ,['citation-journal']," Sandset E, Krarup LH, Berge E, Kjeldsen SE, Julius S, Holzhauer B. Predictors of stroke recurrence in high‐risk, hypertensive patients.  Journal of Hypertension 2010;28(A):E33. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1097/01.hjh.0000378299.43296.c3', 'https://scholar.google.com/scholar_lookup?title=Predictors+of+stroke+recurrence+in+high‐risk,+hypertensive+patients&author=E+Sandset&author=LH+Krarup&author=E+Berge&author=SE+Kjeldsen&author=S+Julius&author=B+Holzhauer&publication_year=2010&hl=en']",,https://doi.org/10.1097/01.hjh.0000378299.43296.c3, VALUE 2004 {published data only}  ,included,CD008170-bbs2-0043,
CD008170-bib-0086,"Zanchetti A, Julius S, Kjeldsen S, McInnes GT, Hua T, Weber M, et al. ",Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial, Journal of Hypertension ,2006,24,    ,['citation-journal']," Zanchetti A, Julius S, Kjeldsen S, McInnes GT, Hua T, Weber M, et al. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial.  Journal of Hypertension 2006;24(11):2163‐8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/01.hjh.0000249692.96488.46', 'https://www.ncbi.nlm.nih.gov/pubmed/17053536', 'https://scholar.google.com/scholar_lookup?title=Outcomes+in+subgroups+of+hypertensive+patients+treated+with+regimens+based+on+valsartan+and+amlodipine:+an+analysis+of+findings+from+the+VALUE+trial+&author=A+Zanchetti&author=S+Julius&author=S+Kjeldsen&author=GT+McInnes&author=T+Hua&author=M+Weber&publication_year=2006&hl=en']",17053536,https://doi.org/10.1097/01.hjh.0000249692.96488.46, VALUE 2004 {published data only}  ,included,CD008170-bbs2-0043,
CD008170-bib-0087,"Xiao WY, Ning N, Tan MH, Jiang XS, Zhou L, Liu L, et al. ",Effects of antihypertensive drugs losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension combined with isolated impaired fasting glucose, Hypertension Research ,2016,39,    ,['citation-journal']," Xiao WY, Ning N, Tan MH, Jiang XS, Zhou L, Liu L, et al. Effects of antihypertensive drugs losartan and levamlodipine besylate on insulin resistance in patients with essential hypertension combined with isolated impaired fasting glucose.  Hypertension Research 2016;39(8):321‐6. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1038/hr.2015.155', 'https://www.ncbi.nlm.nih.gov/pubmed/26763851', 'https://scholar.google.com/scholar_lookup?title=Effects+of+antihypertensive+drugs+losartan+and+levamlodipine+besylate+on+insulin+resistance+in+patients+with+essential+hypertension+combined+with+isolated+impaired+fasting+glucose+&author=WY+Xiao&author=N+Ning&author=MH+Tan&author=XS+Jiang&author=L+Zhou&author=L+Liu&publication_year=2016&hl=en']",26763851,https://doi.org/10.1038/hr.2015.155, Xiao 2016 {published data only}  ,included,CD008170-bbs2-0044,
CD008170-bib-0088,"Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD. ",Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease, Nephrology Dialysis Transplantation ,2008,23,    ,['citation-journal']," Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.  Nephrology Dialysis Transplantation 2008;23(2):573‐9. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1093/ndt/gfm731', 'https://scholar.google.com/scholar_lookup?title=Renal+and+cardiac+effects+of+antihypertensive+treatment+with+ramipril+vs+metoprolol+in+autosomal+dominant+polycystic+kidney+disease+&author=R+Zeltner&author=R+Poliak&author=B+Stiasny&author=RE+Schmieder&author=BD+Schulze&publication_year=2008&hl=en']",,https://doi.org/10.1093/ndt/gfm731, Zeltner 2008 {published data only}  ,included,CD008170-bbs2-0045,
CD008170-bib-0089,"Wright JT, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, et al. ",Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease, JAMA ,2002,288,    ,['citation-journal']," Wright JT, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease.  JAMA 2002;288(19):2421‐31. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1001/jama.288.19.2421', 'https://www.ncbi.nlm.nih.gov/pubmed/12435255', 'https://scholar.google.com/scholar_lookup?title=Effect+of+blood+pressure+lowering+and+antihypertensive+drug+class+on+progression+of+hypertensive+kidney+disease+&author=JT+Wright&author=G+Bakris&author=T+Greene&author=LY+Agodoa&author=LJ+Appel&author=J+Charleston&publication_year=2002&hl=en']",12435255,https://doi.org/10.1001/jama.288.19.2421, AASK 2002 {published data only}  ,excluded,CD008170-bbs2-0046, Mortality and morbidity data were not reported in a form that could be extracted and entered  
CD008170-bib-0090,"Chowdhury EK, Owen A, Ademi Z, Krum H, Johnston CI, Wing LMH, et al. ",Short‐ and long‐term survival in treated elderly hypertensive patients with or without diabetes: findings from the Second Australian National Blood Pressure study, American Journal of Hypertension ,2014,27,    ,['citation-journal']," Chowdhury EK, Owen A, Ademi Z, Krum H, Johnston CI, Wing LMH, et al. Short‐ and long‐term survival in treated elderly hypertensive patients with or without diabetes: findings from the Second Australian National Blood Pressure study.  American Journal of Hypertension 2014;27(2):199‐206. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1093/ajh/hpt212', 'https://www.ncbi.nlm.nih.gov/pubmed/24249722', 'https://scholar.google.com/scholar_lookup?title=Short‐+and+long‐term+survival+in+treated+elderly+hypertensive+patients+with+or+without+diabetes:+findings+from+the+Second+Australian+National+Blood+Pressure+study+&author=EK+Chowdhury&author=A+Owen&author=Z+Ademi&author=H+Krum&author=CI+Johnston&author=LMH+Wing&publication_year=2014&hl=en']",24249722,https://doi.org/10.1093/ajh/hpt212, ANBP2 2003 {published data only}  ,excluded,CD008170-bbs2-0047," Not double‐blinded trial; study used PROBE (prospective, randomized, open‐label design, with blinded assessments of end points) design  "
CD008170-bib-0091,"Wing LMH, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, et al. ",A comparison of outcomes with angiotensin‐converting‐‐enzyme inhibitors and diuretics for hypertension in the elderly, New England Journal of Medicine ,2003,348,    ,['citation-journal']," Wing LMH, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, et al. A comparison of outcomes with angiotensin‐converting‐‐enzyme inhibitors and diuretics for hypertension in the elderly.  New England Journal of Medicine 2003;348:583‐92. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1056/NEJMoa021716', 'https://scholar.google.com/scholar_lookup?title=A+comparison+of+outcomes+with+angiotensin‐converting‐‐enzyme+inhibitors+and+diuretics+for+hypertension+in+the+elderly+&author=LMH+Wing&author=CM+Reid&author=P+Ryan&author=LJ+Beilin&author=MA+Brown&author=GL+Jennings&publication_year=2003&hl=en']",,https://doi.org/10.1056/NEJMoa021716, ANBP2 2003 {published data only}  ,excluded,CD008170-bbs2-0047," Not double‐blinded trial; study used PROBE (prospective, randomized, open‐label design, with blinded assessments of end points) design  "
CD008170-bib-0092,"Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, et al. ",Single‐drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents, New England Journal of Medicine ,1993,328,    ,['citation-journal']," Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, et al. Single‐drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.  New England Journal of Medicine 1993;328(13):914‐21. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1056/NEJM199304013281303', 'https://scholar.google.com/scholar_lookup?title=Single‐drug+therapy+for+hypertension+in+men.+A+comparison+of+six+antihypertensive+agents+with+placebo.+The+Department+of+Veterans+Affairs+Cooperative+Study+Group+on+Antihypertensive+Agents+&author=BJ+Materson&author=DJ+Reda&author=WC+Cushman&author=BM+Massie&author=ED+Freis&author=MS+Kochar&publication_year=1993&hl=en']",,https://doi.org/10.1056/NEJM199304013281303, Materson 1993 {published data only}  ,excluded,CD008170-bbs2-0048," The outcome of this study was BP control rate, so we could not extract relevant data "
CD008170-bib-0093,"Okin PM, Kjeldsen SE, Lindholm LH, Dahlof B, Devereux RB. ",The relationship of electrocardiographic left ventricular hypertrophy to decreased serum potassium, Blood Pressure ,2012,21,    ,['citation-journal']," Okin PM, Kjeldsen SE, Lindholm LH, Dahlof B, Devereux RB. The relationship of electrocardiographic left ventricular hypertrophy to decreased serum potassium.  Blood Pressure 2012;21:146‐52. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.3109/08037051.2011.649537', 'https://www.ncbi.nlm.nih.gov/pubmed/22243363', 'https://scholar.google.com/scholar_lookup?title=The+relationship+of+electrocardiographic+left+ventricular+hypertrophy+to+decreased+serum+potassium+&author=PM+Okin&author=SE+Kjeldsen&author=LH+Lindholm&author=B+Dahlof&author=RB+Devereux&publication_year=2012&hl=en']",22243363,https://doi.org/10.3109/08037051.2011.649537, Okin 2012 {published data only}  ,excluded,CD008170-bbs2-0049, Outcomes were grouped and analyzed according to blood potassium. We have no available data to extract associated with different medications  
CD008170-bib-0094,"Peng J, Zhao Y, Zhang H, Liu Z, Wang Z, Tang M, et al. ",Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high‐normal blood pressure, Hypertension Research ,2015,38,    ,['citation-journal']," Peng J, Zhao Y, Zhang H, Liu Z, Wang Z, Tang M, et al. Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high‐normal blood pressure.  Hypertension Research 2015;38(2):123‐31. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1038/hr.2014.148', 'https://www.ncbi.nlm.nih.gov/pubmed/25273554', 'https://scholar.google.com/scholar_lookup?title=Prevention+of+metabolic+disorders+with+telmisartan+and+indapamide+in+a+Chinese+population+with+high‐normal+blood+pressure+&author=J+Peng&author=Y+Zhao&author=H+Zhang&author=Z+Liu&author=Z+Wang&author=M+Tang&publication_year=2015&hl=en']",25273554,https://doi.org/10.1038/hr.2014.148, Peng 2015 {published data only}  ,excluded,CD008170-bbs2-0050, This study included participants with high risk of hypertension but excluded people diagnosed as hypertensive  
CD008170-bib-0095,"Preston RA, Materson BJ, Reda DJ, Williams DW, Hamburger RJ, Cushman WC, et al. ",Age‐race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents, JAMA ,1998,280,    ,['citation-journal']," Preston RA, Materson BJ, Reda DJ, Williams DW, Hamburger RJ, Cushman WC, et al. Age‐race subgroup compared with renin profile as predictors of blood pressure response to antihypertensive therapy. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.  JAMA 1998;280(13):1168‐72. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1001/jama.280.13.1168', 'https://www.ncbi.nlm.nih.gov/pubmed/9777817', 'https://scholar.google.com/scholar_lookup?title=Age‐race+subgroup+compared+with+renin+profile+as+predictors+of+blood+pressure+response+to+antihypertensive+therapy.+Department+of+Veterans+Affairs+Cooperative+Study+Group+on+Antihypertensive+Agents+&author=RA+Preston&author=BJ+Materson&author=DJ+Reda&author=DW+Williams&author=RJ+Hamburger&author=WC+Cushman&publication_year=1998&hl=en']",9777817,https://doi.org/10.1001/jama.280.13.1168, Preston 1998 {published data only}  ,excluded,CD008170-bbs2-0051, The study focused on choice of an initial antihypertensive agent by using renin profile methods versus age‐race methods. There were no available data for this review  
CD008170-bib-0096,"Estacio RO, Jeffers BW, Gifford N, Schrier RW. ",Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes, Diabetes Care ,2000,23,    ,['citation-journal']," Estacio RO, Jeffers BW, Gifford N, Schrier RW. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.  Diabetes Care 2000;23(suppl 2):B54‐64.    PubMed     Google Scholar     ","['https://www.ncbi.nlm.nih.gov/pubmed/10860192', 'https://scholar.google.com/scholar_lookup?title=Effect+of+blood+pressure+control+on+diabetic+microvascular+complications+in+patients+with+hypertension+and+type+2+diabetes+&author=RO+Estacio&author=BW+Jeffers&author=N+Gifford&author=RW+Schrier&publication_year=2000&hl=en']",10860192,, ABCD‐HT 2000 ,additional,CD008170-bbs2-0052,
CD008170-bib-0097,American Diabetes Association. ,Standards of medical care in diabetes, Diabetes Care ,2013,36,    ,['citation-journal'], American Diabetes Association. Standards of medical care in diabetes.  Diabetes Care 2013;36(suppl 1):S11‐66.    PubMed     ,['https://www.ncbi.nlm.nih.gov/pubmed/23264422'],23264422,, ADA 2013 ,additional,CD008170-bbs2-0053,
CD008170-bib-0098,"Atkins D, Best D, Briss PA, Eccles M, Falck‐Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O'Connell D, Oxman AD, Phillips B, Schünemann HJ, Edejer T, Varonen H, Vist GE, Williams JW, Zaza S, GRADE Working Group. ",Grading quality of evidence and strength of recommendations, BMJ ,2004,328,    ,['citation-journal']," Atkins D, Best D, Briss PA, Eccles M, Falck‐Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O'Connell D, Oxman AD, Phillips B, Schünemann HJ, Edejer T, Varonen H, Vist GE, Williams JW, Zaza S, GRADE Working Group. Grading quality of evidence and strength of recommendations.  BMJ 2004;328(7454):1490‐4.    PubMed     Google Scholar     ","['https://www.ncbi.nlm.nih.gov/pubmed/15205295', ""https://scholar.google.com/scholar_lookup?title=Grading+quality+of+evidence+and+strength+of+recommendations&author=D+Atkins&author=D+Best&author=PA+Briss&author=M+Eccles&author=Y+Falck‐Ytter&author=S+Flottorp&author=GH+Guyatt&author=RT+Harbour&author=MC+Haugh&author=D+Henry&author=S+Hill&author=R+Jaeschke&author=G+Leng&author=A+Liberati&author=N+Magrini&author=J+Mason&author=P+Middleton&author=J+Mrukowicz&author=D+O'Connell&author=AD+Oxman&author=B+Phillips&author=HJ+Schünemann&author=T+Edejer&author=H+Varonen&author=GE+Vist&author=JW+Williams&author=S+Zaza&publication_year=2004&hl=en""]",15205295,, Atkins 2004 ,additional,CD008170-bbs2-0054,
CD008170-bib-0099,"Aurell M, Bjorck S. ",Determinants of progressive renal disease in diabetes mellitus, Kidney Int Suppl ,1992,41,    ,['citation-journal']," Aurell M, Bjorck S. Determinants of progressive renal disease in diabetes mellitus.  Kidney Int Suppl 1992;41(suppl 36):S38‐42.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Determinants+of+progressive+renal+disease+in+diabetes+mellitus&author=M+Aurell&author=S+Bjorck&publication_year=1992&hl=en'],,, Aurell 1992 ,additional,CD008170-bbs2-0055,
CD008170-bib-0100,"Niskanen L, Hedner T, Hansson L, Lanke J, Niklason A, CAPPP Study Group. ",Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first‐line therapy with an ACE inhibitor compared with a diuretic/beta‐blocker‐based treatment regimen: a subanalysis of the Captopril Prevention Project (CAPPP), Diabetes Care ,2001,24,    ,['citation-journal']," Niskanen L, Hedner T, Hansson L, Lanke J, Niklason A, CAPPP Study Group. Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first‐line therapy with an ACE inhibitor compared with a diuretic/beta‐blocker‐based treatment regimen: a subanalysis of the Captopril Prevention Project (CAPPP).  Diabetes Care 2001;24:2091‐6.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.2337/diacare.24.12.2091', 'https://www.ncbi.nlm.nih.gov/pubmed/11723089', 'https://scholar.google.com/scholar_lookup?title=Reduced+cardiovascular+morbidity+and+mortality+in+hypertensive+diabetic+patients+on+first‐line+therapy+with+an+ACE+inhibitor+compared+with+a+diuretic/beta‐blocker‐based+treatment+regimen:+a+subanalysis+of+the+Captopril+Prevention+Project+(CAPPP)+&author=L+Niskanen&author=T+Hedner&author=L+Hansson&author=J+Lanke&author=A+Niklason&publication_year=2001&hl=en']",11723089,https://doi.org/10.2337/diacare.24.12.2091, CAPPP 2001 ,additional,CD008170-bbs2-0056,
CD008170-bib-0101,"Casas JP, Chua W, Loukogeorgakis S, Vallance P, Smeeth L, Hingorani AD, et al. ",Effect of inhibitors of the renin‐angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta‐analysis, Lancet ,2005,366,    ,['citation-journal']," Casas JP, Chua W, Loukogeorgakis S, Vallance P, Smeeth L, Hingorani AD, et al. Effect of inhibitors of the renin‐angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta‐analysis.  Lancet 2005;366(9502):2026‐33.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/S0140-6736(05)67814-2', 'https://www.ncbi.nlm.nih.gov/pubmed/16338452', 'https://scholar.google.com/scholar_lookup?title=Effect+of+inhibitors+of+the+renin‐angiotensin+system+and+other+antihypertensive+drugs+on+renal+outcomes:+systematic+review+and+meta‐analysis+&author=JP+Casas&author=W+Chua&author=S+Loukogeorgakis&author=P+Vallance&author=L+Smeeth&author=AD+Hingorani&publication_year=2005&hl=en']",16338452,https://doi.org/10.1016/S0140-6736(05)67814-2, Casas 2005 ,additional,CD008170-bbs2-0057,
CD008170-bib-0102,"Chen N, Zhou M, Yang M, Guo J, Zhu C, Yang J, et al. ",Calcium channel blockers versus other classes of drugs for hypertension, Cochrane Database of Systematic Reviews ,2010,,    ,['citation-journal']," Chen N, Zhou M, Yang M, Guo J, Zhu C, Yang J, et al. Calcium channel blockers versus other classes of drugs for hypertension.  Cochrane Database of Systematic Reviews 2010, Issue 8. [DOI: 10.1002/14651858.CD003654.pub4]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD003654.pub4', 'https://scholar.google.com/scholar_lookup?title=Calcium+channel+blockers+versus+other+classes+of+drugs+for+hypertension&author=N+Chen&author=M+Zhou&author=M+Yang&author=J+Guo&author=C+Zhu&author=J+Yang&publication_year=2010&hl=en']",,https://doi.org/10.1002/14651858.CD003654.pub4, Chen 2010 ,additional,CD008170-bbs2-0058,
CD008170-bib-0103,Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. ,Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada ‐ Treatment of Hypertension, Canadian Journal of Diabetes ,2013,37,    ,['citation-journal'], Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada ‐ Treatment of Hypertension.  Canadian Journal of Diabetes 2013;37(Suppl 1):S117‐8.    PubMed     ,['https://www.ncbi.nlm.nih.gov/pubmed/24070930'],24070930,, CPG 2013 ,additional,CD008170-bbs2-0059,
CD008170-bib-0104,"DeStefano F, Ford ES, Newman J, Stevenson JM, Wetterhall SF, Anda RF, et al. ",Risk factors for coronary heart disease mortality among persons with diabetes, Annals of Epidemiology ,1993,3,    ,['citation-journal']," DeStefano F, Ford ES, Newman J, Stevenson JM, Wetterhall SF, Anda RF, et al. Risk factors for coronary heart disease mortality among persons with diabetes.  Annals of Epidemiology 1993;3:27‐34.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/1047-2797(93)90006-P', 'https://www.ncbi.nlm.nih.gov/pubmed/8287153', 'https://scholar.google.com/scholar_lookup?title=Risk+factors+for+coronary+heart+disease+mortality+among+persons+with+diabetes&author=F+DeStefano&author=ES+Ford&author=J+Newman&author=JM+Stevenson&author=SF+Wetterhall&author=RF+Anda&publication_year=1993&hl=en']",8287153,https://doi.org/10.1016/1047-2797(93)90006-P, DeStefano 1993 ,additional,CD008170-bbs2-0060,
CD008170-bib-0105,"Duprez, D. ",Role of the renin‐angiotensin‐aldosterone system in vascular remodeling and inflammation: a clinical review, Journal of Hypertension ,2006,24,    ,['citation-journal']," Duprez, D. Role of the renin‐angiotensin‐aldosterone system in vascular remodeling and inflammation: a clinical review.  Journal of Hypertension 2006;24:983‐91.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1097/01.hjh.0000226182.60321.69', 'https://www.ncbi.nlm.nih.gov/pubmed/16685192', 'https://scholar.google.com/scholar_lookup?title=Role+of+the+renin‐angiotensin‐aldosterone+system+in+vascular+remodeling+and+inflammation:+a+clinical+review+&author=+Duprez&author=+D&publication_year=2006&hl=en']",16685192,https://doi.org/10.1097/01.hjh.0000226182.60321.69, Duprez 2006 ,additional,CD008170-bbs2-0061,
CD008170-bib-0106,Dzau VJ. ,Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis, Hypertension ,2001,37,    ,['citation-journal'], Dzau VJ. Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis.  Hypertension 2001;37:1047‐52.    Link to article     PubMed     Google Scholar     ,"['https://doi.org/10.1161/01.HYP.37.4.1047', 'https://www.ncbi.nlm.nih.gov/pubmed/11304501', 'https://scholar.google.com/scholar_lookup?title=Tissue+angiotensin+and+pathobiology+of+vascular+disease:+a+unifying+hypothesis&author=VJ+Dzau&publication_year=2001&hl=en']",11304501,https://doi.org/10.1161/01.HYP.37.4.1047, Dzau 2001 ,additional,CD008170-bbs2-0062,
CD008170-bib-0107,"Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. ",Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC), Journal of Hypertension ,2013,31,    ,['citation-journal']," Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).  Journal of Hypertension 2013;31(7):1281‐357.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1097/01.hjh.0000431740.32696.cc', 'https://www.ncbi.nlm.nih.gov/pubmed/23817082', 'https://scholar.google.com/scholar_lookup?title=Task+Force+Members.+2013+ESH/ESC+Guidelines+for+the+management+of+arterial+hypertension:+the+Task+Force+for+the+management+of+arterial+hypertension+of+the+European+Society+of+Hypertension+(ESH)+and+of+the+European+Society+of+Cardiology+(ESC)+&author=G+Mancia&author=R+Fagard&author=K+Narkiewicz&author=J+Redón&author=A+Zanchetti&author=M+Böhm&publication_year=2013&hl=en']",23817082,https://doi.org/10.1097/01.hjh.0000431740.32696.cc, ESH/ESC 2013 ,additional,CD008170-bbs2-0063,
CD008170-bib-0108,"Geiss LS, Rolka DB, Engelgau MM. ","Elevated blood pressure among U.S. adults with diabetes, 1988‐1994", American Journal of Preventive Medicine ,2002,22,    ,['citation-journal']," Geiss LS, Rolka DB, Engelgau MM. Elevated blood pressure among U.S. adults with diabetes, 1988‐1994.  American Journal of Preventive Medicine 2002;22:42‐8.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/S0749-3797(01)00399-3', 'https://www.ncbi.nlm.nih.gov/pubmed/11777678', 'https://scholar.google.com/scholar_lookup?title=Elevated+blood+pressure+among+U.S.+adults+with+diabetes,+1988‐1994&author=LS+Geiss&author=DB+Rolka&author=MM+Engelgau&publication_year=2002&hl=en']",11777678,https://doi.org/10.1016/S0749-3797(01)00399-3, Geiss 2002 ,additional,CD008170-bbs2-0064,
CD008170-bib-0109,"Higgins JPT, Green S (editors). ","Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011",,,,. Available from www.cochrane‐handbook.org.   ,['citation-other']," Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.    ",[],,, Higgins 2011 ,additional,CD008170-bbs2-0065,
CD008170-bib-0110,Heart Outcomes Prevention Evaluation (HOPE) Study investigators. ,Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICROHOPE substudy, Lancet ,2000,355,    ,['citation-journal'], Heart Outcomes Prevention Evaluation (HOPE) Study investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICROHOPE substudy.  Lancet 2000;355:253‐9.    Link to article     PubMed     ,"['https://doi.org/10.1016/S0140-6736(99)12323-7', 'https://www.ncbi.nlm.nih.gov/pubmed/10675071']",10675071,https://doi.org/10.1016/S0140-6736(99)12323-7, HOPE 2000 ,additional,CD008170-bbs2-0066,
CD008170-bib-0111,"Inzucchi SE, Sherwin RS. ",The prevention of type 2 diabetes mellitus, Endocrinology and Metabolism Clinics of North America ,2005,34,    ,['citation-journal']," Inzucchi SE, Sherwin RS. The prevention of type 2 diabetes mellitus.  Endocrinology and Metabolism Clinics of North America 2005;34(1):199‐219.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.ecl.2004.11.008', 'https://www.ncbi.nlm.nih.gov/pubmed/15752928', 'https://scholar.google.com/scholar_lookup?title=The+prevention+of+type+2+diabetes+mellitus&author=SE+Inzucchi&author=RS+Sherwin&publication_year=2005&hl=en']",15752928,https://doi.org/10.1016/j.ecl.2004.11.008, Inzucchi 2005 ,additional,CD008170-bbs2-0067,
CD008170-bib-0112,"James PA, Oparil S, Carter BL, et al. ",2014 evidence‐based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8), JAMA ,2014,311,    ,['citation-journal']," James PA, Oparil S, Carter BL, et al. 2014 evidence‐based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).  JAMA 2014;311(5):507‐20.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1001/jama.2013.284427', 'https://www.ncbi.nlm.nih.gov/pubmed/24352797', 'https://scholar.google.com/scholar_lookup?title=2014+evidence‐based+guideline+for+the+management+of+high+blood+pressure+in+adults:+report+from+the+panel+members+appointed+to+the+Eighth+Joint+National+Committee+(JNC+8)+&author=PA+James&author=S+Oparil&author=BL+Carter&publication_year=2014&hl=en']",24352797,https://doi.org/10.1001/jama.2013.284427, JNC‐8 2014 ,additional,CD008170-bbs2-0068,
CD008170-bib-0113,"Kasiske BL, Kalil RS, Ma JZ, Liao M, Keane WF. ",Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta regression analysis, Annals of Internal Medicine ,1993,118,    ,['citation-journal']," Kasiske BL, Kalil RS, Ma JZ, Liao M, Keane WF. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta regression analysis.  Annals of Internal Medicine 1993;118(2):129‐38.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.7326/0003-4819-118-2-199301150-00009', 'https://www.ncbi.nlm.nih.gov/pubmed/8416309', 'https://scholar.google.com/scholar_lookup?title=Effect+of+antihypertensive+therapy+on+the+kidney+in+patients+with+diabetes:+a+meta+regression+analysis+&author=BL+Kasiske&author=RS+Kalil&author=JZ+Ma&author=M+Liao&author=WF+Keane&publication_year=1993&hl=en']",8416309,https://doi.org/10.7326/0003-4819-118-2-199301150-00009, Kasiske 1993 ,additional,CD008170-bbs2-0069,
CD008170-bib-0114,"Kocks MJ, de Zeeuw D, Navis GJ. ",Optimal blood pressure control and antihypertensive regimens in hypertensive renal disease, Current Opinion in Nephrology and Hypertension ,2002,11,    ,['citation-journal']," Kocks MJ, de Zeeuw D, Navis GJ. Optimal blood pressure control and antihypertensive regimens in hypertensive renal disease.  Current Opinion in Nephrology and Hypertension 2002;11:135‐40.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1097/00041552-200203000-00002', 'https://www.ncbi.nlm.nih.gov/pubmed/11856904', 'https://scholar.google.com/scholar_lookup?title=Optimal+blood+pressure+control+and+antihypertensive+regimens+in+hypertensive+renal+disease+&author=MJ+Kocks&author=D+Zeeuw&author=GJ+Navis&publication_year=2002&hl=en']",11856904,https://doi.org/10.1097/00041552-200203000-00002, Kocks 2002 ,additional,CD008170-bbs2-0070,
CD008170-bib-0115,"Li ECK, Heran BS, Wright JM. ",Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension, Cochrane Database of Systematic Reviews ,2014,,    ,['citation-journal']," Li ECK, Heran BS, Wright JM. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.  Cochrane Database of Systematic Reviews 2014, Issue 8. [DOI: 10.1002/14651858.CD009096.pub2]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD009096.pub2', 'https://scholar.google.com/scholar_lookup?title=Angiotensin+converting+enzyme+(ACE)+inhibitors+versus+angiotensin+receptor+blockers+for+primary+hypertension+&author=ECK+Li&author=BS+Heran&author=JM+Wright&publication_year=2014&hl=en']",,https://doi.org/10.1002/14651858.CD009096.pub2, Li 2014 ,additional,CD008170-bbs2-0071,
CD008170-bib-0116,MARVAL Study Investigators. ,Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus, Circulation ,2002,106,    ,['citation-journal'], MARVAL Study Investigators. Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus.  Circulation 2002;106:672‐8.    Link to article     PubMed     ,"['https://doi.org/10.1161/01.CIR.0000024416.33113.0A', 'https://www.ncbi.nlm.nih.gov/pubmed/12163426']",12163426,https://doi.org/10.1161/01.CIR.0000024416.33113.0A, MARVAL 2002 ,additional,CD008170-bbs2-0072,
CD008170-bib-0117,"Pahor M, Psaty BM, Alderman MH, Applegate WB, Williamson JD, Furberg CD. ",Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes, Diabetes Care ,2000,23,    ,['citation-journal']," Pahor M, Psaty BM, Alderman MH, Applegate WB, Williamson JD, Furberg CD. Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.  Diabetes Care 2000;23:888‐92.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.2337/diacare.23.7.888', 'https://www.ncbi.nlm.nih.gov/pubmed/10895836', 'https://scholar.google.com/scholar_lookup?title=Therapeutic+benefits+of+ACE+inhibitors+and+other+antihypertensive+drugs+in+patients+with+type+2+diabetes+&author=M+Pahor&author=BM+Psaty&author=MH+Alderman&author=WB+Applegate&author=JD+Williamson&author=CD+Furberg&publication_year=2000&hl=en']",10895836,https://doi.org/10.2337/diacare.23.7.888, Pahor 2000 ,additional,CD008170-bbs2-0073,
CD008170-bib-0118,PROGRESS Collaborative Study Group. ,Randomised trial of perindopril based blood pressure‐lowering regimen among 6108 individuals with previous stroke or transient ischaemic attack, Lancet ,2001,358,    ,['citation-journal'], PROGRESS Collaborative Study Group. Randomised trial of perindopril based blood pressure‐lowering regimen among 6108 individuals with previous stroke or transient ischaemic attack.  Lancet 2001;358:1033‐41.    Link to article     PubMed     ,"['https://doi.org/10.1016/S0140-6736(01)06178-5', 'https://www.ncbi.nlm.nih.gov/pubmed/11589932']",11589932,https://doi.org/10.1016/S0140-6736(01)06178-5, PROGRESS 2001 ,additional,CD008170-bbs2-0074,
CD008170-bib-0119,"Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid‐Smith P, Danks DM. ",Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1, Lancet ,1994,343,    ,['citation-journal']," Ravine D, Gibson RN, Walker RG, Sheffield LJ, Kincaid‐Smith P, Danks DM. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1.  Lancet 1994;343(8901):824‐7.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/S0140-6736(94)92026-5', 'https://www.ncbi.nlm.nih.gov/pubmed/7908078', 'https://scholar.google.com/scholar_lookup?title=Evaluation+of+ultrasonographic+diagnostic+criteria+for+autosomal+dominant+polycystic+kidney+disease+1+&author=D+Ravine&author=RN+Gibson&author=RG+Walker&author=LJ+Sheffield&author=P+Kincaid‐Smith&author=DM+Danks&publication_year=1994&hl=en']",7908078,https://doi.org/10.1016/S0140-6736(94)92026-5, Ravine 1994 ,additional,CD008170-bbs2-0075,
CD008170-bib-0120,RENAAL Study Investigators. ,Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy, New England Journal of Medicine ,2001,345,    ,['citation-journal'], RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.  New England Journal of Medicine 2001;345:861‐9.    Link to article     ,['https://doi.org/10.1056/NEJMoa011161'],,https://doi.org/10.1056/NEJMoa011161, RENAAL 2001 ,additional,CD008170-bbs2-0076,
CD008170-bib-0121,"The Nordic Cochrane Centre, The Cochrane Collaboration. ",Review Manager (RevMan),,2014,,.   ,['citation-other']," The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.    ",[],,, RevMan 2014 [Computer program] ,additional,CD008170-bbs2-0077,
CD008170-bib-0122,"Saha SA, Molnar J, Arora RR. ",Tissue angiotensin‐converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta‐analysis of randomized placebo‐controlled clinical trials, Diabetes Obesity and Metabolism ,2008,10,    ,['citation-journal']," Saha SA, Molnar J, Arora RR. Tissue angiotensin‐converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta‐analysis of randomized placebo‐controlled clinical trials.  Diabetes Obesity and Metabolism 2008;10(1):41‐52.    Google Scholar     ",['https://scholar.google.com/scholar_lookup?title=Tissue+angiotensin‐converting+enzyme+inhibitors+for+the+prevention+of+cardiovascular+disease+in+patients+with+diabetes+mellitus+without+left+ventricular+systolic+dysfunction+or+clinical+evidence+of+heart+failure:+a+pooled+meta‐analysis+of+randomized+placebo‐controlled+clinical+trials+&author=SA+Saha&author=J+Molnar&author=RR+Arora&publication_year=2008&hl=en'],,, Saha 2008 ,additional,CD008170-bbs2-0078,
CD008170-bib-0123,"Siebenhofer A, Plank J, Horvath K, Berghold A, Sutton AJ, Sommer R, et al. ",Angiotensin receptor blockers as anti‐hypertensive treatment for patients with diabetes mellitus: meta‐analysis of controlled double‐blind randomized trials, Diabetic Medicine ,2004,21,    ,['citation-journal']," Siebenhofer A, Plank J, Horvath K, Berghold A, Sutton AJ, Sommer R, et al. Angiotensin receptor blockers as anti‐hypertensive treatment for patients with diabetes mellitus: meta‐analysis of controlled double‐blind randomized trials.  Diabetic Medicine 2004;21(1):18‐25.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/j.1464-5491.2004.01122.x', 'https://www.ncbi.nlm.nih.gov/pubmed/14706049', 'https://scholar.google.com/scholar_lookup?title=Angiotensin+receptor+blockers+as+anti‐hypertensive+treatment+for+patients+with+diabetes+mellitus:+meta‐analysis+of+controlled+double‐blind+randomized+trials+&author=A+Siebenhofer&author=J+Plank&author=K+Horvath&author=A+Berghold&author=AJ+Sutton&author=R+Sommer&publication_year=2004&hl=en']",14706049,https://doi.org/10.1111/j.1464-5491.2004.01122.x, Siebenhofer 2004 ,additional,CD008170-bbs2-0079,
CD008170-bib-0124,"Strippoli GFM, Craig ME, Craig JC. ",Antihypertensive agents for preventing diabetic kidney disease, Cochrane Database of Systematic Reviews ,2005,,    ,['citation-journal']," Strippoli GFM, Craig ME, Craig JC. Antihypertensive agents for preventing diabetic kidney disease.  Cochrane Database of Systematic Reviews 2005, Issue 4. [DOI: 10.1002/14651858.CD004136.pub2]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD004136.pub2', 'https://scholar.google.com/scholar_lookup?title=Antihypertensive+agents+for+preventing+diabetic+kidney+disease&author=GFM+Strippoli&author=ME+Craig&author=JC+Craig&publication_year=2005&hl=en']",,https://doi.org/10.1002/14651858.CD004136.pub2, Strippoli 2005 ,additional,CD008170-bbs2-0080,
CD008170-bib-0125,"Strippoli GFM, Bonifati C, Craig ME, Navaneethan SD, Craig JC. ",Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease, Cochrane Database of Systematic Reviews ,2006,,    ,['citation-journal']," Strippoli GFM, Bonifati C, Craig ME, Navaneethan SD, Craig JC. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease.  Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD006257]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD006257', 'https://scholar.google.com/scholar_lookup?title=Angiotensin+converting+enzyme+inhibitors+and+angiotensin+II+receptor+antagonists+for+preventing+the+progression+of+diabetic+kidney+disease+&author=GFM+Strippoli&author=C+Bonifati&author=ME+Craig&author=SD+Navaneethan&author=JC+Craig&publication_year=2006&hl=en']",,https://doi.org/10.1002/14651858.CD006257, Strippoli 2006 ,additional,CD008170-bbs2-0081,
CD008170-bib-0126,"Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. ",Beta‐blockers for hypertension, Cochrane Database of Systematic Reviews ,2017,,    ,['citation-journal']," Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Opie LH. Beta‐blockers for hypertension.  Cochrane Database of Systematic Reviews 2017, Issue 1. [DOI: 10.1002/14651858.CD002003.pub5]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD002003.pub5', 'https://scholar.google.com/scholar_lookup?title=Beta‐blockers+for+hypertension&author=CS+Wiysonge&author=HA+Bradley&author=J+Volmink&author=BM+Mayosi&author=LH+Opie&publication_year=2017&hl=en']",,https://doi.org/10.1002/14651858.CD002003.pub5, Wiysonge 2017 ,additional,CD008170-bbs2-0082,
CD008170-bib-0127,"Wright JM, Musini VM. ",First‐line drugs for hypertension, Cochrane Database of Systematic Reviews ,2009,,    ,['citation-journal']," Wright JM, Musini VM. First‐line drugs for hypertension.  Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD001841.pub2]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD008161', 'https://scholar.google.com/scholar_lookup?title=First‐line+drugs+for+hypertension&author=JM+Wright&author=VM+Musini&publication_year=2009&hl=en']",,https://doi.org/10.1002/14651858.CD008161, Wright 2009 ,additional,CD008170-bbs2-0083,
CD008170-bib-0128,"Wu HY, Huang JW, Lin HJ, Liao WC, Peng YS, Hung KY, et al. ",Comparative effectiveness of renin‐angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta‐analysis, BMJ ,2013,347,    ,['citation-journal']," Wu HY, Huang JW, Lin HJ, Liao WC, Peng YS, Hung KY, et al. Comparative effectiveness of renin‐angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta‐analysis.  BMJ 2013;347(7933):f6008. [DOI: 10.1136/bmj.f6008]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1136/bmj.f6008', 'https://www.ncbi.nlm.nih.gov/pubmed/24157497', 'https://scholar.google.com/scholar_lookup?title=Comparative+effectiveness+of+renin‐angiotensin+system+blockers+and+other+antihypertensive+drugs+in+patients+with+diabetes:+systematic+review+and+bayesian+network+meta‐analysis+&author=HY+Wu&author=JW+Huang&author=HJ+Lin&author=WC+Liao&author=YS+Peng&author=KY+Hung&publication_year=2013&hl=en']",24157497,https://doi.org/10.1136/bmj.f6008, Wu 2013 ,additional,CD008170-bbs2-0084,
CD008170-bib-0129,"Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GWK, Wright JM. ",First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for hypertension, Cochrane Database of Systematic Reviews ,2015,,    ,['citation-journal']," Xue H, Lu Z, Tang WL, Pang LW, Wang GM, Wong GWK, Wright JM. First‐line drugs inhibiting the renin angiotensin system versus other first‐line antihypertensive drug classes for hypertension.  Cochrane Database of Systematic Reviews 2015, Issue 1. [DOI: 10.1002/14651858.CD008170.pub2]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD008170.pub2', 'https://scholar.google.com/scholar_lookup?title=First‐line+drugs+inhibiting+the+renin+angiotensin+system+versus+other+first‐line+antihypertensive+drug+classes+for+hypertension+&author=H+Xue&author=Z+Lu&author=WL+Tang&author=LW+Pang&author=GM+Wang&author=GWK+Wong&author=JM+Wright&publication_year=2015&hl=en']",,https://doi.org/10.1002/14651858.CD008170.pub2, Xue 2015 ,other_versions,CD008170-bbs2-0085,
